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Abstract
North American ginseng is a unique and widely used medicinal plant. Ontario has
become the largest grower of ginseng in North America (NA), having been grown in
Ontario for over 50 years. Components isolated from NA ginseng include
polysaccharides, ginsenosides, peptides, polyacetylenic alcohols, and fatty acids.
Polysaccharides (PS), the major medicinal fraction derived from NA ginseng root, have
shown

several

biological

activities

including

anti-carcinogenic,

anti-aging,

immunostimulatory and antioxidant activity.
This work focused on nanoprocessing of ginseng PS for enhancing their
immunostimulation. Herein, we have developed a novel approach to synthesize ginseng
PS nanoparticles (NPs) from NA ginseng root. NPs of ginseng PS were prepared using a
microfluidic device and compared to other conventional wet chemical processes
including nanoprecipitation and reverse microemulsion. Depending on the experimental
conditions, microfluidics was found to provide unimodal PS spheres down to 20 nm
(±4nm) with very narrow particle size distributions. In addition, the immunostimulating
effect of the PS NPs was investigated on Murine macrophage cell lines, with the results
revealing an enhanced production of proinflammatory mediators in a concentration
dependent manner.
Until now, no research has explored the cellular uptake and biodistribution of ginseng PS,
owing to a lack of suitable detection techniques in living cells. This work examines
confocal laser scanning microscopy (CLSM), which is a simple and efficient procedure to
examine the cellular distribution of ginseng PS. This procedure utilized a one-pot strategy
with fluorescein-5-thiosemicarbazide (FTSC) to introduce a thiosemicarbazide group
onto the aldehyde group at the reducing saccharide end to form a stable amino derivative
through reductive amination. The results demonstrated that the labeled ginseng PS
nanostructure showed high fluorescence with minimal changes in PS molecular weight.
The labeled PS exhibited almost no cytotoxicity effect against tumor induced
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macrophage cell lines (RAW 264.7) while retaining high immunostimulating activity
similar to the non-labeled ginseng PS.
Furthermore, PS NPs were encapsulated within biodegradable gelatin nanospheres for the
sustained release of PS. An in situ two-step desolvation method was employed to
encapsulate ginseng PS NPs within gelatin nanospheres. The experimental data showed
that the gelatin nanospheres were uniform with average diameter 180 nm (±10 nm) with
the pore size of 3.84 nm. To confirm the encapsulation of PS in gelatin NPs, fluorescentlabeled PS was encapsulated in gelatin NPs, which were identified by CLSM. The release
kinetics reveal that the rate of PS release from gelatin nanocarriers decreases with an
increase in the concentration of cross-linker. The results also indicate that acidic
conditions can delay the release rate of PS from gelatin nanocarriers. The encapsulated
PS NPs exhibited almost no cytotoxicity effect against the investigated macrophage cell
lines (RAW 264.7). The encapsulated PS also showed high immunostimulating activity
similar to the non-encapsulated ginseng PS NPs. This approach can be utilized for the
integration into capsules for subsequent oral drug delivery.
Ultraviolet (UV) radiation induced skin damages may result in cancerous skin lesions,
and acceleration of skin aging. Skin aging involves an imbalance of the endogenous
antioxidant system with a resulting increase of free radical levels and inflammation.
Ginseng root is promising to enhance antioxidant supplementation that may inhibit such
imbalance due to its proven anti-oxidative and anti-inflammatory properties. Therefore,
for the first time, we investigated the possible beneficial effects of topical formulations
containing NA ginseng PS NPs to inhibit UVB induced oxidative damage. Induction of
photoaging was conducted on SKH-1 hairless mice through UVB irradiation at 300
mJ/cm2. The treatment groups (n =5) were as follows: Control (BC), ginseng PS (bulk),
ginseng PS (NPs) and labeled ginseng PS NPs which were added into the base cream and
applied to the dorsal skin of mice. Two experiments were performed to assess ginseng PS
protective properties: one was pre-treatment and the other was post-treatment. Skin and
blood were collected, inflammatory cytokine (IL-1Β, IL-6, and TNFα) levels were
measured using ELISA, and the skin was analyzed through histology. The ginseng PS
NPs treated blood and skin sample showed a significant reduction in all cytokine
ii

production compared to the control. Additionally, histological analysis showed pretreatment of ginseng PS NPs prevented epidermal damage and proliferation. Therefore,
the results suggest the possible usefulness of topical formulations containing ginseng PS
NPs to prevent UVB induced skin damage.
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1.1 Ginseng

Ginseng, a member of the Araliaceae family, is a slow growing perennial herb. Its
scientific genus name Panax, comes from the greek panakeria which means ‘Universal
remedy’. Literally, the word signifies “cure all”, which depicts the conventional belief
that ginseng has unique properties which can be used as a medicine for all diseases. [1].
Currently, ginseng is one of the top-selling therapeutic plant in the world [2]. The most
widely used ginseng species includes Panax ginseng C. A. Mayer (Asian or Korean
ginseng), Panax quinquefolius L. (North American ginseng), Panax notoginseng
(Burkill), Panax japonicus (T. Nees) C. A. Mey. (Japanese ginseng), F.H. Chen (PN,
Sanchi ginseng) and Panax vietnamensis Ha & Grushv. (Vietnamese ginseng) [1, 3-5].
North American (NA) ginseng grows in the northern areas of the United States and
within both British Columbia and Ontario. Native North Americans historically used the
roots of this plant for relieving fever and stomach misery [6]. Successful cultivation of
NA ginseng started from the 1800s and now it becomes one of the most popular
supplementary medicines.
Ontario produces around 2,000 tonnes of ginseng root per year, of which 90% is
commercially supplied to Asia. According to Agriculture and Agri-Food Canada, Canada
exports around 3,000 tonnes of NA ginseng roots to China and other Asian markets,
especially Hong Kong annually. The price of ginseng exports to all countries in total had
26.8% growth from 2007-2010 [7].

1.2 Components of ginseng

Ginseng

contains

many

active

components,

including

peptides,

fatty

acids,

polyacetylenes, ginsenosides and polysaccharides. Among these, isolated polyacetylenes,
ginsenosides and polysaccharides have gained significant interest due to their diverse
biological activities [1, 2].
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Polyacetylenes are long organic polymer chains with a (C2H2)n repeating structure . There
are six major polyactylenes that are common across many species of ginseng including
ginsenoyne-A, panaxynol, panaxydol, panaxytriol, panaxyne and ginsenoyne – C. The
ratio of these compounds changes based on the growth conditions of the ginseng as well
as its post-harvest processing. Many of these compounds have been shown to play an
important role in ginsengs anti-tumor and anti-cancer properties. For instance, in a mouse
xenograft model, panaxydol was shown to decrease the toxic side effects connected with
standard cancer treatment such as weight loss, peripheral neuropathy and hematotoxicity
[8]. Furthermore, panaxydol has also been shown to preferentially induce apoptosis in
human cancer cells through a caspase-dependent and mitochondrial-mediated response.
In addition, panaxytriol has been shown to cause significant cytotoxicity and inhibit DNA
synthesis in multiple tumor cell lines [9].

Ginsenosides have been claimed to be the active ingredients of ginseng for many years.
Ginsenosides are low molecular weight steroidal saponins unique to the Panax genus.
The two most common groups of ginsenosides are the protopanaxadiol and
protopanaxatriol ginsenosides. These groups differ in their 4-trans ring steroidal
backbone [10]. In order to create unique ginsenosides from the protopanaxadiol
backbone, sugar moieties are attached to the β-OH at carbon 3 and/or carbon 20.
Likewise, unique ginsenosides are created by the addition of sugar groups to the α-OH at
carbon 6 and/or the β-OH at carbon 20 of the protopanaxatriol backbone [10]. The
differential addition of sugar side chains has resulted in the presence of over 100 unique
ginsenosides. Rg1, Re, Rb3, Rc , Rb1, and Rd are the main ginsenosides in NA ginseng.
They showed various biological activities including anti-inflammatory, anti-oxidant,
immunomodulatory, anti-cancer and anti-diabetic [10].
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Figure 1.1. Chemical structures of (a) ginseng polyacetylene, and (b) ginsenosides (Rb1
and Rg1) (adapted from [11, 12]).

1.3 Ginseng polysaccharides

1.3.1

Chemical structure of ginseng polysaccharides

Ginseng polysaccharides (PS) mainly consists of starch-like and pectin PS. The ginseng
starch-like PS contains 3-branched α-D-(1,6)-glucans and 6-branched α-D-(1,4)-glucan
whereas the ginseng pectin PS is comprised of galactouronic acid (GalA), arabinose
(Ara), and galactose (Gal). Ginseng PS also contains glucose (Glc), mannose (Man),
rhamnose (Rha), and glucouronic acid (GlcA) [13]. Ginseng PS are mainly formed from
a complex chain of monosaccharides which contain D-galactose, L-arabinose, Dgalacturonic acid, L-rhamnose, and D-galactosyl residues (Figure 1.2). They are
connected together through glycosidic bonds, which form a complex macromolecular
structure with as molecular weight range from 3.5x103 to 2x106 Da. There structure
provides multiple physiochemical properties and biological activities [14]. CVT-E002TM
(sold commercially as COLD-FX®) is a commercially available product of poly-

4

furanosyl-pyranosyl-saccharides from NA ginseng root, and has been clinically used for
the prevention of upper respiratory tract infections [4, 15].

Two acidic PS fractions were isolated from ginseng roots by Tomada et al. Their
molecular weights were estimated as 1.6x105 and 5.5x104 Da respectively by using gel
permeation chromatography [16]. Zhang et al. fractionated ginseng PS, demonstrating
that it consists of two different types of PS, one is neutral PS and the other is acidic PS.
By hydrolysis with α-amylase, they found that neutral PS consists of starch-like glucans
and arabinogalactan. They also reported acidic PS contains Gal, Ara, Glc, Man, GalA,
GlcA [13].

Figure 1.2. Proposed chemical structure of ginseng polysaccharides (adapted from [14]).

1.3.2

Extraction of polysaccharides from ginseng

There are different extraction approaches that have been developed for PS isolation from
ginseng plant. Hot-water treatment, a classical method requires long extraction times and
high temperatures for the extraction of PS. Ultrasound assisted extraction is another
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powerful extraction technique for isolating PS extraction from various plant tissues. This
method involves high-intensity and high-frequency sound waves and their interaction
with materials [17].
A methodology developed in Professor’s Lui and Charpentier’s group at the University of
Western Ontario, Canada, for extracting PS from NA ginseng involves first soaking
ground ginseng roots in water at 40°C. After extraction, the solution was filtered,
concentrated by rotary evaporator and lyophilized by a freeze dryer. To isolate PS from
the ginseng, a solution of aqueous extract in distilled water was prepared and then the
crude polysaccharides were precipitated by the addition of ethanol. Finally, the crude
polysaccharide was collected by centrifugation and lyophilized by a rotary evaporator
[18]. Zhang et al. also extracted PS from the root of Panax ginseng using hot distilled
water at 100°C for 4 h and then filtered. After repeating the extraction process, the filtrate
was centrifuged to remove water-insoluble materials, concentrated using a rotary
evaporator, and then precipitated by adding ethanol. Eventually, the PS was collected by
centrifugation and dried [13].

1.3.3

Biological activities of polysaccharides

Wang et al. investigated ginseng PS on immune function. Their work revealed that the PS
components significantly stimulated phagocytosis of the reticuloendothelial system [19].
PS was also found to enhance the B-lymphatic to T-lymphatic cell ratio. Na et al.
identified that acidic PS extracted from ginseng effectively increased the humoral
immune response for orally administered antigen, which was mediated by CCL3 cytokine
[chemokine (C-C motif) ligand 3]. Hence, PS can be considered as vaccine supplement
for oral immunization [20]. Ginseng PS was also investigated for immunomodulatory
effects in murine peritoneal macrophages [21]. Lim et al. reported that PS markedly
enhanced the lysosomal phosphatase activity and also the phagocytic index of peritoneal
macrophages. Their results revealed that PS significantly upregulated peritoneal
macrophages production of H2O2 and nitric oxide compared to the untreated control.
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Again, PS markedly increased the cell viability of peritoneal macrophages, indicating that
ginseng PS can be considered as an effective nonspecific immunomodulatory agent [21].
Park et al. reported an acidic PS from the roots of Panax ginseng stimulated the
immunostimulating property by nitric oxide production [22].

Besides the immunomodulatory effects, ginseng PS have also been investigated as
anticancer and hypoglycaemic agents. Shin et al. reported that ginseng PS increased the
cytotoxic and phagocytic activity of macrophages, and also the production of different
cytokines including IL-1, IL-6, TNF-α, and IFN-γ. They suggested that PS can be used as
a therapeutic agent for the treatment of cancer [23]. Ni et al. have investigated a neutral
ginseng PS along with 5-fluorouracil (5-FU) using Sarcoma-180 (S180) tumor-bearing
mice through intragastric administration for the treatment of cancer. They found that PS
increased the natural killer cell cytotoxicity, the phagocytosis and nitric oxide production
of macrophages, the proliferation of lymphocytes, and also the level of TNF-α in serum.
They also reported that ginseng PS lowered the side-effects of 5-FU to the immune
system in S180-bearing mice [24]. Park et. al. used acidic PS that was isolated from the
leaves of Panax ginseng for the treatment of human prostate cancer. Their results
revealed that acidic PS in combination with paclitaxel or cisplatin can be used as an anticancer therapeutic agent. Acidic PS was found to markedly enhance the therapeutic effect
of paclitaxel or cisplatin and also lowered haematopoietic complications induced by
systemic chemotherapy or radiation therapy [25]. Xie et al. investigated the PS fraction
that was isolated from NA ginseng berry for the treatment of diabetes. Their results
indicated that PS markedly improved the glucose tolerance level in diabetic ob/ob mice
[26].
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1.4 Nanosizing and drug delivery

Nanomedicine is an important emerging area for our healthcare. Nowadays nanomedicine
is routinely investigated for exploring controlled drug delivery system which can improve
the absorption of active pharmaceutical ingredients (API). Moreover, nanotechnology in
medicine enhances targeting of various cells and extracellular elements inside the body
while targeting the delivery of drugs, therapeutic agents, and genetic materials. Recently,
research on nanosizing of pharmaceutical and therapeutic agents and their targeted
delivery using various routes of administration have shown tremendous promise [27].
The aim of controlled drug delivery is to develop new strategies for the delivery of these
so called API’s at a predetermined, predictable and controlled rate. To accomplish this,
drug delivery systems are fabricated in such a way that they can efficiently interact with
the biological systems at the cellular, tissue and organism level [28]. Controlled drug
delivery also helps protect the API against chemical and enzymatic degradation in the
systematic circulation [29]. Nanomedicines can also help improve the pharmacodynamic
and pharmacokinetic properties of the API [30]. In comparison to microparticles, NPs can
provide higher intercellular uptake due to their smaller size and relative mobility. Hence,
they are more available for targeted drug delivery.

1.4.1

Nanomedicines for oral delivery

The oral route is perhaps the most popular and convenient method of drug administration.
The intestinal epithelium (IE) is extremely absorptive area in the gastrointestinal (GI)
tract consisting of villi, which help increase the entire absorptive surface area up to 400
m2 [31]. In spite of its several advantages, oral administration faces several drawbacks,
particularly as the mucus barrier has a tendency to prevent drug penetration [32]. For
macromolecular drugs such as the PS of interest to this thesis, it is difficult for them to
cross the intestinal cells to reach into the systematic circulation. The size of
macromolecular drug is also problem which can prevent the molecule from crossing the
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paracellular pathway in the GI tract [33]. These limitations can cause poor oral
bioavailability for many drugs.

One solution to help overcome these physical and degradative barriers is by nanosizing of
the drug. Nanoparticulate drugs show better adhesion and interaction with cells, tissues
and organs due to their very small dimensions [33]. Nanomedicines can cross the GI
tract barriers through three different pathways based on the size of NPs. When the NPs
size is less than 5 µm, they are usually absorbed by M cells of Peyer's patches, which is
termed lymphatic uptake. If the particles size becomes smaller (<500 nm), they can be
absorbed by intestinal enterocytes via endocytosis (endocytotic uptake). Nanomedicines
with a particle size less than <50 nm show “kneading” between intestinal epithelial cells
and can reach the systematic circulation easily. [32-34]. All these pathways are shown
schematically in Figure 1.3.
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Figure 1.3. Schematic of possible interaction of nanomedicines within intestinal barrier.

1.4.2

Synthesis of polymeric nanoparticles

Nanoparticles (NPs) offer tunable properties that are advantageous compared to their
bulk counterparts. Organic, inorganic or hybrid NPs are utilized in various fields
including pharmaceutics, catalysis, coatings, analytics etc. [35].

Typically, NPs can be synthesized using two general approaches: (1) Top-down
approach: NPs are formed from the initial bulk material by various routes including,
10

nanoprecipitation, emulsion, spray drying, or milling processes, (2) Bottom-up approach:
NPs are formed by in situ reactive synthesis from solubilized molecular precursors (e.g.
sol-gel) [36]. Both techniques are briefly described below which are utilized in this
thesis.

i)

Nanoprecipitation method

Fessi et al. first developed the nanoprecipitation technique for the preparation of polymer
NPs [37]. This method offers several advantages including being rather simple and fast.
Here, the formation of NPs is immediate and the entire synthesis process is completed in
only one step. Two different solvents are used in this technique including, (i) solvent
with: dissolved drug molecules and (ii) “non-solvent”: which helps precipitate the drug
have contacted with the solvent phase due to a decrease in drug solubility.
Nanoprecipitation normally occurs quickly after adding the non-solvent to the polymer
solution by rapid desolvation [38]. A schematic illustration of the nanoprecipitation
technique is shown in Figure 1.4.

The mechanism of NP formation through nanoprecipitation follows two basic steps;
nucleation of small aggregates of solute followed by growth of the nuclei. According to
Lamer’s proposed theory, nucleation starts in a supersaturated solution and the NPs
growth stops as soon as it reaches colloidal stability [39]. The NPs growth strongly
depends on the solute concentration and the solution viscosity [40]. The viscosity of the
solution needs to be sufficiently low to suppress excessive contact between the solid
molecules, such as ginseng PS chains as examined in this work. Depending on the
characteristics of the polymer chains, NPs can continue growing through a process
known as Oswald ripening. By adding stabilizing agents this growth mechanism can be
minimized [40]. During the nanoprecipitation process, due to the homogeneous
distribution of the polymer chains in solution, the preferred shape of the resulting NPs is
spherical [36, 40]. The advantages of this approach include; no need for high
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temperatures, sonication, surfactants, or toxic solvents, all of which may cause structural
changes during processing. NP formation using the nanoprecipitation approach has been
reported for a wide range of preformed polymers, including cellulose derivatives, poly
(D,L-lactic-co-glycolic acids), or poly ɛ-caprolactones [41].

Figure 1.4. Schematic illustration of the synthesis of polymer NPs formation using the
nanoprecipitation method.

ii)

Microemulsion method

Microemulsion is a thermodynamically stable and transparent solution consisting of
water and oil, stabilized by surfactants and/or co-surfactant. Microemulsions were first
reported by Hoar and Schulman in 1943 [42]. They prepared a clear single-phase solution
by titrating a milky emulsion with hexanol. From then, the microemulsion technique has
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gained immense interest as a popular technique for the preparation of NPs. There are
normally two types of droplet dispersions in microemulsion, either oil-in-water (o/w) or
water-in-oil (w/o). By controlling the concentration of dispersed phases and surfactant,
the droplet size can be tuned with a size range of 5-100 nm. Oil and water phases show a
tendency to separate into two distinct layers based on their thermodynamic
incompatibility that can be prevented by using surfactants.

The chemical structure of the surfactant has a large influence on the nature of the
microemulsion. A typical surfactant molecule contains both hydrophilic and hydrophobic
functionalities. During microemulsion formation, the surfactant molecules absorb at the
oil-water interface showing affinity of hydrophilic functionality with water and
hydrophobic functionality with the oil phase, respectively. The surfactant also helps
control the mismatch in polarity with the solvent through forming the well-known micelle
structure [43]. In the case of ionic surfactants containing a single hydrocarbon chain,
microemulsions are only formed in the presence of a co-surfactant. However, for double
chain hydrocarbon ionic and some non-ionic surfactants, co-surfactants are not required
to form microemulsions. Other than the type of surfactant, microemulsion formation also
depends on the oil/water/surfactant/co-surfactant ratio, pH and temperature of the
dispersion

[44].

Water-in-oil

microemulsions

are

also

known

as

“reverse

microemulsions” where controlled aqueous pools form inside the micelles of the oil
phase in the presence of a surfactant. Here an organic solvent is used as a continuous oil
phase, which is present in a higher proportion relative to water. A diagrammatic
representation of both o/w and w/o microemulsions are shown in Figure 1.5.
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Figure 1.5. Schematic of polymer nanoparticle formation using the microemulsion
methods (a) oil-in-water and (b) water-in-oil.

iii)

Microfluidics

Compared to a batch process, a microfluidic platform offers a controlled synthesis of
polymeric NPs in a continuous fashion. Inside the microfluidic channels, the
hydrodynamic flow facilitates synthesis of monodispersed NPs by mixing of solvent/antisolvent in an controlled manner [45]. The microfluidic approach for polymers was first
reported for PLGA-b-PEG copolymers in acetonitrile/water [46]. Here the size and
polydispersity of the NPs can be optimized by tuning the flow rates, polymer composition
and concentration. The process parameters need to be optimized by minimizing the
mixing time that facilitates a homogeneous environment for the controlled growth of the
NPs [46]. Micromixing structures are used to improve mixing and minimize mixing time
in the microfluidic device. Two commonly used microfluidic devices for monodisperse
particle formation are: T-junctions [47] and flow-focusing nozzles [48] which are
dependent on the channel geometry for controlling the particle shape as shown in Figure
1.6.
The T-junction microchannel is perhaps the most convenient and widely used geometry
for controlled droplet formation in microfluidic devices. The size and uniformity of the
droplets can be tuned by changing the experimental parameters, including viscosity,
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flowrate of solvent and anti-solvents, interfacial tensions and microchannel geometry
[49]. The resulting droplet size also depends on the pressure of both the dispersed and
continuous phases. When the pressure of the dispersed phase increases, the droplet size
increases. When the pressure of the continuous phase increases, the droplet size
decreases. Flow-focusing nozzles have also been reported for forming monodispersed
polymeric particles, polymer-encapsulated cells, and ion-crosslinkable thermosensitive
gels [36, 48].

Polymeric NP formation inside microfluidic devices following a microemulsion
mechanism has been reported previously by several research groups [50, 51]. In this case,
depending on the hydrodynamic instability the immiscible polymeric solution breaks up
into droplets, with microparticles then forming followed by solvent evaporation.
Microfluidic polymeric NP formation based on the nanoprecipitation mechanism have
gained significant recent interest. Professor Langers group of MIT has reported the
synthesis of monodispersed PLGA-PEG NPs based on nanoprecipitation process in a
microfluidic channel by rapid mixing of polymer-acetonitrile solutions and water using
flow focusing device [48].

Figure 1.6. Droplet formation with different mechanism (a) flow focusing and (b) Tjunction.
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1.5 Dye labeling for imaging of cells
1.5.1

Fluorescence imaging

To date, fluorescence based techniques have been greatly encouraged in bioimaging due
to their inherent advantages, such as high sensitivity, high selectivity, convenience and
non-invasive character [52]. For examining the in vitro and in vivo biodistribution
response of newly developed API, it is necessary to follow their cellular uptake and
endocytosis [53]. The internalization and penetration of the cells and tissues by API can
be efficiently monitored by fluorescent microscopy, if the API is tagged with a stable
fluorescent marker [53]. Covalently bound fluorescent labels can offer a promising tool
to obtain highly stable fluorescently labeled particles for an appreciable period of time
[54]. Recently, confocal laser scanning microscopy (CLSM) has become an effective
microscopic tool that provides valuable morphological and functional information on the
cells and tissues [55]. A successful utilization and interpretation of CLSM depends on
several experimental parameters including excitation and emission wavelength,
fluorescence intensity, lifetime and stability of the fluorescent label material. However,
leakage of the fluorescent label from the matrix makes it very difficult to locate the signal
from fluorescent labeled API. Therefore, a stable fluorescent label is of crucial
importance for the sensitivity of quantitative and qualitative detection for the successful
contrast required for CLSM imaging [55].
The presence of various functional groups in PS allows for their modification and finetuning of properties for biomedical applications. Consequently, several methods have
been developed for the modification and derivatization of PS using their lateral functional
groups (e.g. -OH, -COOH, -CHO) to perform etherification, esterification, amidation,
sulphation, reduction amination [56, 57]. The most commonly used technique for the
fluorescent labeling of saccharides is the reductive amination-based method, which
introduces an aromatic amine to the aldehyde group at the reducing end of saccharides
[58, 59]. Many researchers have examined and reported on different fluorescent organic
dyes

as

markers,

including

rhodamine
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110,

O-2-aminoethyl

fluorescein,

5-

aminofluorescein, and 8-aminonaphthalene-1,3,6-trisulfonate [60-62]. But low quantum
yield and poor photostability often pose a problem for these dyes, especially during
fluorescence microscopic analysis [62]. Recently, intensive efforts have been undertaken
to covalently link fluoresceinamine, fluorescein isothiocyanate (FITC), lissamine
rhodamine B sulfonyl chloride (LRSC) with saccharides [62, 63]. However, low yield,
too many reaction steps, pH dependence, complex reaction procedures and long reaction
time limit their convenience for labeling of saccharides [62, 63]. In addition, fluorescein5-thiosemicarbazide (FTSC) is another fluorescent labeling agent which has been used as
a marker to label polymers [62, 64, 65]. The results showed FTSC has potent
fluorescence intensity and intrinsic reactivity of its thiosemicarbazide group onto the
aldehyde group of the polymers. FTSC has also proven to be friendly to living cells and
compatible with the argon laser coupled to fluorescent instruments [62, 64, 65].

1.5.2

Intracellular uptake of the fluorescent nanoparticles

The intracellular uptake of fluorescent NPs followed different mechanism based on their
physiochemical properties. Three significant type of delivery methods for cellular
internalization are used: (i) passive (ii) active and (iii) facilitated [66].
The cellular internalization of fluorescent labeled NPs follows the passive delivery
method. Here, a non-specific cellular endocytosis results in NP sequestration within the
endocytic vesicles and leads to specific fluorescent points within the cytoplasm [66].
These fluorescent points remain within the endosomes and lysosomes for several days.
This passive delivery method is one of the first mechanisms employed by cell lines.
Major advantage of passive delivery is that further modification of the NP surface is not
required [66]. A diagrammatic representation of passive delivery method is shown in
Figure 1.7a.
Facilitated method is used to deliver the surface modified/functionalized fluorescent NPs.
Typically, protein, peptide or lipid molecules are conjugated to the NPs surface that
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facilitates the electrostatic interaction with the cell membrane. A diagrammatic
representation of facilitated delivery method is shown in Figure 1.7b,c [66]. Active
delivery system can be performed using different physical methods including
electroporation, microinjection and gene gun. Microinjection method uses a fine-tipped
glass micro-capillary for the delivery of fluorescent NPs directly within the cell
cytoplasm [66] (Figure 1.7 e). Electroporation method uses an electric field to generate a
temporal hydrophilic pore in the plasma membrane which allows fluorescent NPs to enter
directly to the cytosol. This method was utilized to deliver DNA into the cells (Figure 1.6
d). Gene gun is an effective, rapid and simple method for the delivery of fluorescent NPs
into the cell. This delivery system uses a powerful puff of helium which blast the
fluorescent NPs directly into the cell cytoplasm [66, 67]. A diagrammatic representation
of gene gun delivery method is shown in Figure 1.7f.

Figure 1.7. Methods of intracellular uptake of fluorescent nanoparticles (a) passive
delivery by nonspecific endocytosis, (b) facilitated delivery assisted by transfection
agent: liposomes, (c) facilitated delivery assisted by transfection agent: peptides or
proteins, (d) active delivery: electroporation, (e) active delivery: microinjection and (f)
active delivery: gene gun (adapted from [66]).
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1.6 Drug delivery system
1.6.1

Controlled drug delivery

In the case of conventional drug delivery, the drug is released immediately after
administration (also called burst release). So, the drug concentration in the blood stream
increases rapidly to a very high value (“peak”) and then falls down quickly (“trough”)
because of drug elimination (Figure 1.8). For every drug there is a plasma level inside the
body, above which, the drug becomes toxic and below which, are not effective. For most
drugs, it is not possible to maintain the plasma drug concentration at the ideal level.
Therefore, modified drug delivery is necessary for prolonged and enhanced drug release
after administration [68]. Modified drug delivery approaches are used to prolong the
drug release by reducing dosing frequency (extended release), or release only at some
point after the initial administration, or release the drug to a specific target in the body
(so-called “targeted” release). The main goal of the modified drug delivery or controlled
drug delivery (CDD) approach is to maintain the drug concentration in the desired
therapeutic range after administration. An ideal CDD system not only preserves
medications that are quickly degraded by the body, it releases drug in a desired and
controlled manner helping to increase patient comfort and/or improve compliance [28,
69].
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Figure 1.8. Drug release profile for conventional (burst release and repeated dose) and
controlled release within effective concentration region.

Recently, nano-sized carriers or nanocarriers (NCs) have become more effective as they
can be uptaken easily by cells or tissues compared to the larger size delivery systems.
There are several clinically used NCs based CDD systems which are commercially
available. For instance, liposomal formulations (for cancer therapy), colloidal gold, silica
and magnetic NPs are used [70]. Generally, after drug release the mononuclear
phagocytic system (MPS) recognizes and clears the NCs from the systemic circulation
[70]. If prolonged presence of NCs in the blood is desired for targeted delivery, the
surface of the NPs can be modified by conjugating ligands or hydrophilic polymers.
Sometimes, surface modification is needed to tune the surface charge of the NCs.
Negatively charged biological cell membranes show tendency to efficiently uptake
positively charges NCs [70, 71].
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Nowadays, hydrogel has attained immense interest as nanocarriers for CDD. Hydrogels
are hydrophilic polymers with the ability to imbibe large quantities of water. They are
biocompatible and capable of encapsulating or loading both hydrophobic and hydrophilic
drugs [72]. Another unique property of hydrogels is, with a small change in pH or
temperature they have tendency to undergo reversible volume phase transition (Figure
1.8). This criterion enhances controlled drug release. pH-sensitive hydrogel is also
attractive for controlled release by using pH variations inside the body including
gastrointestinal tract, vagina, blood vessels etc. [73].

Change in pH

Drug loaded gel
Drug release through
the swollen network

Figure 1.9. Schematic representation of drug release from pH sensitive hydrogels.

1.6.2

Gelatin as controlled drug delivery system

Gelatin is a natural and one of the most commonly used hydrogel. It is usually obtained
from bovine bone or pig skin by the thermal denaturation of collagen. The major
advantages are biodegradability, nontoxicity, unique gel-forming ability, and relatively
low antigenicity [74]. Being a protein, gelatin is composed of a unique sequence of amino
acids (Figure 1.11). With the exception of tryptophan, gelatin contains all other essential
amino acids which are linked together by peptide bonds to form the primary structure
[75]. Multiple functionalities of this structure offer more possibilities to chemical
modification as well as covalent attachment of drugs [76]. These advantages combining
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with nanosizing of gelatin make gelatin NPs as a promising controlled drug delivery
carrier.

Although gelatin NPs synthesis has been reported by many research groups,
monodispersity and nanosizing are still major challenges. Gelatin NPs were first
developed by Marty et al. by dissolving gelatin using a desolvating agent such as ethanol,
acetone, causing salting out phenomenon [77]. The major steps of this method involve
the desolvation of gelatin by using a desolvating agent and then crystallization of gelatin
particles based on electrolyte-nonelectrolyte interaction. Here, controlling the various
parameters such as pH, temperature, stirring speed etc. are crucial to obtain uniform
shaped gelatin NPs [77]. Tabata et al. have employed the emulsification technique to
prepare gelatin NPs by using 1:1 mixture of chloroform and toluene as an organic phase,
sorbitan monooleaste as an emulsifier and glutaraldehyde as the cross-linking agent [75].
Luisi et al. employed the reverse microemulsions formation technique to synthesize
gelatin NPs. Briefly, aqueous gelatin with the concentration of 9.5% was poured into a
surfactant (AOT) solution to form micelle. Then, carbodimide was used as the crosslinker for stabilizing the particles [78]. By avoiding the use of surfactants or toxic organic
solvents, Coester et al. developed a two-step desolvation method for the preparation of
gelatin NPs [74]. In this method, an aqueous solution of gelatin was prepared and then a
desolvating agent, acetone was added, and after that glutaraldehyde was added as crosslinker to stabilize the gelatin NPs [74].
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Figure 1.10. Primary chemical structure of gelatin, and gelatin network formation by
cross-linking using glutaraldehyde as a cross-linker (adapted from [78]).

Active pharmaceutical ingredients (API) such as drugs can be loaded into gelatin NPs
either during NP synthesis [79] or after synthesis [80]. Both of the above methods can
lead to a solution or dispersion of the drugs within gelatin matrix or surface by chemical
conjugation or physical adsorption. The availability of amino and carboxylic
functionalities of the crosslinked gelatin NPs facilitates the covalent linking with API
[79]. Different anticancer drugs such as doxorubicin, cytarabine, dactinomycin, cisplatin,
hypocrellin B, methotrexate and mitomycin C were loaded in gelatin NPs by different
research groups and they found controlled release of these drugs from the carrier [28, 79,
81]. Gelatin microspheres were also reported to encapsulate ginsenoside Rg1, an active
ingredient of ginseng [82]. Fluorescent dyes such as TMR dextran, Texas Red succinyl
chloride, fluoresceinamine can also be coupled with gelatin NPs for cellular uptake
studies [74]. Hence, considering the potentiality as a carrier, there is an opportunity to use
gelatin NPs for loading ginseng PS or fluorescent labeled PS that can enhances controlled
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release of ginseng PS. At the same time, it is possible to track the transport and action
within living cells.

1.7 Immunomodulation
The human immune system is a vital part of human life as it protects the body against
harmful pathogens and internal damage. In order to protect the body, the immune system
recognizes pathogens, eliminates them and whenever possible generates immunological
memory [83]. Immune responses can be divided into two broad classifications, innate
and adaptive [83].

The innate immune response is the first line of defense against an invading pathogen
[84]. The innate immune response includes: the anatomical barriers that aim to prevent a
pathogen from entering the body, the recognition of pathogens by Pattern Recognition
Receptors (PRR) expressed in macrophages, neutrophils and dendritic cell (DC) and
activation of the complement system, that all work together to eliminate the pathogen
[85]. Finally, the innate immune response helps control the spread of pathogens. The
ability of the innate immune system to respond immediately to pathogen invasion is
accomplished by sensing what is considered a pathogen through detecting pathogen
associated molecular patterns (PAMPs) [85].

The adaptive immune system on the other hand is characterized by its ability to recognize
pathogens in a specific manner and the ability to generate immunological memory. The
main cell types of the adaptive immune system are B and T cells that have clonotypic
receptors for billions of different antigens present in pathogens. These single specificity
receptors allow for the differentiation between pathogens and the specific recognition of
pathogens [86]. However, in order for a pathogen to be recognized by a B or T cell it
must be phagocytosed and processed by an antigen-presenting cell (APC). Once a T cell
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has been presented with its appropriate antigen it will differentiate into effector and
memory cells. The effector cells will begin to aid in the removal of the pathogen while
memory cells will remain in the body long after the infection has been cleared. Due to the
coordination required to initiate an adaptive immune response, these responses are not as
immediate as the innate immune response and usually take one to two days to begin.
However, once memory cells are present in the body, the adaptive immune response can
begin much faster if the body is reinfected with the same pathogen [85, 86].

Immunomodulators or biological response modifier (BRMs) are the substance that can
interact with the host immune system and then upregulate or downregulate the host
immune response [87]. The body usually produces small amount of these compound.
After the first introduction of diagnostic antibody, the utilization of BRMs has been
rapidly expanded.

Now, BRMs has become popular in immunotherapy and they are

widely used in autoimmune disorder, oncology, transplantation medicine and
inflammatory diseases. The function of BRMs can be passive or active in
immunotherapy. For example, BRMs can passively increase the immunologic response to
tumor cells, or they can act actively by altering the growth of tumor cell. Most of the
immunomodulators are biopharmaceuticals, including IL-2, IFN, monoclonal antibody
and such compounds are still being investigated [87, 88]. Plant PS have been reported to
possess benign biological properties. They have also been shown to act as
immunomodulator. They can either upregulate or downregulate the immune response of
the host immune system [88].
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1.7.1

Macrophage-mediated innate immunity

Macrophages are large mononuclear phagocytic cells which was first recognized by
Metchnikoff. Macrophages are formed through differentiation of monocytes which is
originate from haematopoietic stem cells in the bone marrow. Depending on the different
tissue types, macrophages are called as kupffer cells (liver), alveolar macrophages (lung),
crypt macrophages, osteoclasts (bone), microglia (brain) etc. [89]. Macrophage-mediated
innate immune response is the first line of defense against any foreign materials or
harmful pathogens. Innate immune system recognises pathogens, eliminates and kill the
pathogens and then generates immunological memory for adaptive immune system.
Macrophages act as immune cell through different ways: (i) direct action: directly kill
microorganism or destroy tumor cell through phagocytosis, (ii) indirect action:
production of reactive oxygen compound and cytokines which can activate other cells,
and (iii) restore tissue damage [89, 90].

Macrophages respond to invading pathogens by initiating phagocytosis and then
synthesis and release of pro-inflammatory cytokines. Microorganisms (bacteria, fungi,
protozoa, viruses) have pathogen-associated molecular patterns (PAMPs) that are
identified by pattern recognition receptors on macrophages [91]. The left side of Figure
1.10 illustrates the process of phagocytosis, which involves engulfment of pathogens into
an intracellular vesicle called a phagosome. Phagosomes then merge with lysosomes to
form a phagolysosome, where degradation of the pathogens occurs by enzymes, then
cellular release of the degraded material by exocytosis happens. The right side of Figure
1.10 illustrates that pathogens binding to surface receptors of the macrophage also signal
the transcription of pro-inflammatory cytokines in the cell's nucleus. Cytokines are then
produced in the cytoplasm and these pro-inflammatory proteins are secreted from the cell
[92]. Ginseng polysaccharide activates the macrophages function which leads to the
enhanced production of proinflammatory mediators [18].
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Figure 1.11. The role of macrophage cell line in response to pathogen infection.

1.7.2

Ginseng modulation of immune function

Ginseng have been shown to have different immunomodulatory activities including
immunostimulatory and immunosuppressive activity. Both the aqueous and alcohol
extract

have

been

reported

to

possess

immunomodulatory

effects.

The

immunomodulatory effects of ginseng mainly depend on the experimental condition and
also on the choice of solvent of used during extraction [18, 93]. Studies demonstrated that
ginseng PS usually acts as immunostimulant [18]. For example, CVT-E002™ a natural
health product of NA ginseng PS, clinically used for the prevention of upper respiratory
illness [15]. CVT-E002™ also can inhibit the allergic airway inflammation and hyperresponsiveness, lowered the neutrophils activation and LPS-induced IL-2 and IFN-γ
production in spleen. Therefore, CVT-E002™ can suppresses induced immuneinflammatory response [15]. Zhao et. al. (2010) reported that ginseng PS can suppress
induced proinflammatory responses [94]. Their results showed that PS can inhibit the
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immunological response in mice associated with collagen-induced arthritis [94]. Study
demonstrated that ginseng PS may have protective effect against Staphylococcus aureusinfected septic mice through intravenous (IV) administration [95]. The results reveal that
the protective effect of ginseng PS may be attributed to the immunosuppressive effect of
PS which inhibits the early acute inflammation in the investigated mice [95].

A recent study investigated the protective effect of ginseng PS against influenza virus
induced mice through the intranasal and IV administration [96]. The results reveal that
ginseng PS successfully decreased the production of cytokine (IL-6), and eventually can
protect against influenza virus [96]. Another study suggest that acidic and neutral ginseng
PS can stimulate B cells, macrophages and lymphocytes [16]. They also reported that
ginseng PS increased the natural killer cell cytotoxicity, level of TNF-α in serum, and
enhance NO production by macrophages [16]. A recent study reported that PS with
higher molecular weight (MW) (>100 kDa) acted as better immunostimulating agent
compare to the low MW ginseng PS [4]. Their result also reveal that PS can activate the
B and T cells function, and also increase cytokines production of macrophages and the
phagocytic activity [4].
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1.8 Scope of research

Polysaccharides are a major active component of NA ginseng root (Panax quinquefolius).
Recently, significant work has been carried out by various research groups on the
immunomodulation effect of ginseng PS extracts on macrophage cell lines. It has been
found that due to their large aggregate size, a significant portion of these macromolecules
cannot pass the cell barrier of the gastrointestinal tract. Moreover, due to the absence of
any fluorescent groups in the ginseng PS, it is not possible to monitor the transport of PS
inside the cells. Therefore, this work focuses on nanoprocessing of ginseng PS for
enhancing the efficacy, labeling of PS for tracking the cell and encapsulation within a
nanocarrier for the controlled delivery.

The step-wise objectives of this thesis are as follows:


Extraction of PS from NA ginseng root using aqueous extraction method. The PS
portion was further isolated and purified using ethanol and ‘Sevag reagent’
respectively.



Synthesis of ginseng PS NPs using a microfluidic device and compared to other
conventional wet chemical processes including nanoprecipitation and reverse
microemulsion techniques.



Synthesis of fluorescent labeled ginseng PS NPs for monitoring the transport of PS
NPs inside the cell.



Synthesis of gelatin nanosphere and encapsulation of ginseng PS NPs within gelatin
nanocarrier by using the ‘two-step desolvation’ method.



Investigation of immunostimulating effect of ginseng PS using animal model
(Albino male mice) and compared to in vitro study



Investigation of photo-protective effect of ginseng PS NPs against UVB-induced
skin damage in the hairless mice.
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1.9 Thesis organization

This thesis follows the integrated article style.

Chapter 1 contains a brief introduction to the research background, brief review,
objectives and overview of the thesis.

Chapter 2 provides the synthesis of ginseng PS NPs in a controlled manner by using a
continuous flow microfluidic device and compare the NPs to other conventional wet
chemical processes including nanoprecipitation and the reverse microemulsion technique.
It also contains various characterization study to confirm the morphology and size of the
NPs using SEM, TEM, DLS and FTIR. The biological activity of these PS NPs using
Murine macrophage cell lines (RAW 264.7) for the production of nitric oxide, tumor
necrosis factor-α, interleukin-1β and interleukin-6 cytokines are also depicted here.

Chapter 3 contains synthesis of fluorescent labeling of ginseng PS NPs. This procedure
utilizes a one-pot strategy with fluorescein-5-thiosemicarbazide (FTSC) to introduce a
thiosemicarbazide group onto the aldehyde group at the saccharide. It includes the
characterization study of the labeled ginseng PS NPs using UV, FTIR, GPC,
photoluminescence and fluorescence microscopy in order to confirm attachment and any
structural changes. This chapter also provides the cell uptake studies using Macrophage
cell lines (RAW264.7) by inverted confocal microscopy to examine the dye uptake time.
Furthermore, the cytotoxicity and the immunostimulating property of the labeled ginseng
PS NPs against the living cells also illustrated in this chapter.
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Chapter 4 provides the synthesis method of ginseng PS NPs encapsulated gelatin
nanospheres through two step desolvation method. It also includes different
characterization studies that prove the morphology of gelatin nanospheres and the
presence of ginseng PS within gelatin nanocarriers. The releasing rate and swelling
behavior of the nanoparticulate system with respect to pH and crosslinking are also
illustrated in this chapter. The immunostimulating and cytotoxicity effects of the
encapsulated ginseng PS are also investigated in this chapter.

Chapter 5 based on in vivo study using Albino male mice. This chapter includes the
immune-stimulating effect of orally administered ginseng PS materials and then compare
to the in vitro study.

Chapter 6 contains the investigation of photo-protective effect of ginseng PS NPs against
UVB- induced skin damage in the hairless mice. Two different types of experiment
named (i) pre-treatment and (ii) post-treatment are illustrated in this chapter.

Skin

histology using optical and confocal microscopy images are also presented here. This
chapter also contains the production of pro-inflammatory mediators in the blood and skin
sample that are attributed to the cause of UV-induced skin damage.

Chapter 7 gives conclusions and recommendations for future study. Nanosizing,
fluorescent labeling, nanoencapsulation of ginseng PS and their applications are
summarized. Based on the summarized results, recommendations for future studies are
also presented.
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Chapter 2

Microfluidic synthesis of ginseng polysaccharide
nanoparticles for immunostimulating action on
macrophage cell lines
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Abstract
North American (NA) ginseng root (Panax quinquefolium) has become of increasing
scientific interest due to its immune-enhancing properties. Herein, we have developed a
novel approach to synthesize ginseng polysaccharide nanoparticles (NPs) from NA
ginseng for enhancing their immunostimulation. Nanoparticles of ginseng polysaccharide
were prepared using a microfluidic device and compared to other conventional wet
chemical processes including nanoprecipitation and reverse microemulsion. The
morphology and size of the NPs were characterized by SEM, TEM, DLS and FTIR.
Depending on the experimental conditions, microfluidics was found to provide unimodal
polysaccharide spheres down to 20 nm (±4nm) with very narrow particle size
distributions. In addition, the immunostimulating effect of the polysaccharide NPs was
investigated on Murine macrophage cell lines, with the results revealing an enhanced
production of all proinflammatory mediators in a concentration dependent manner. The
proposed microfluidic system has the advantages of ease of fabrication, simplicity, and a
fast and low-cost process that is capable of producing ginseng polysaccharide NPs with
demonstrated enhancement of immunostimulation of macrophage cell lines.

2.1 Introduction
Ginseng is an important source of plant polysaccharides that belongs to the Araliaceae
family. The two most commonly recognized species of ginseng are Asian ginseng (Panax
ginseng) and North American ginseng (Panax quinquefolium). In the last two decades,
ginseng has become the second-highest selling herbal medicine in North America, being
used as a supplement for enhancement of immunity, stress relief, prevention of aging,
cardiovascular diseases, HIV etc [1-4]. Polysaccharides (PS), the major medicinal
fractions derived from ginseng (Panax quinquefolium) root, have been shown to provide
immune-modulating effects [5-10]. In particular, COLD-FX®, a commercially available
natural health product isolated from North American ginseng root, contains 80% polyfuranosyl-pyranosyl-saccharides, and has been clinically used for the prevention of upper
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respiratory tract infections [3, 11]. Macrophage cells have been found the most important
components of host defense against bacterial infections, neoplastic cells, killing tumor
cells etc [12, 13].

Under physiological conditions, PS stimulate the activity of

macrophages and enhance the production of different mediators or active components,
such as interferon-γ, tumor necroses factor (TNF)- α, interleukin (IL)- 1,2,6, nitric oxide
etc [5, 6, 9, 10].

Recently, significant work has been carried out by various research groups on the
immune stimulation effect of ginseng PS extracts on macrophage cell lines [3, 14-17]. It
has been found that due to their large aggregate size, a significant portion of these
macromolecules cannot pass the cell barrier of the gastrointestinal tract [18]. Nowadays,
nanotechnology in medicine (or nanomedicine) is being actively used for rational and
targeted delivery of pharmaceutical, therapeutic, and diagnostic agents to specific cells
and extracellular elements of the body [19-21]. The possible mechanisms for the
nanoparticles (NPs) to pass through the gastrointestinal (and other physiological) barriers
include: (1) paracellular passage—particles “kneading” between intestinal epithelial cells
due to their extremely small size (<50 nm); (2) endocytotic uptake—particles absorbed
by intestinal enterocytes through endocytosis (particles size<500 nm); and (3) lymphatic
uptake—particles adsorbed by M cells of the Peyer's patches (particle size <5 μm) [7-9].

Hence, by nanosizing ginseng PS extracts, they may be more effective in bypassing the
GI barrier. So far, no research has reported on ginseng PS NPs synthesis and their
biological activity. Therefore, this work focuses on nanosizing ginseng PS using a facile
approach and observing their effect on immunological activity.

Typically, polymeric NPs are synthesized in bulk by precipitation/ solvent exchange
methods or by emulsification using surfactants. But these processes are very slow and
difficult to remove solvents from the products, which can be toxic [22, 23]. Recently,
microfluidic reactors exhibit significant advantages over ordinary bulk scale reactors.
These include a low unit cost, reduced sample consumption, faster reaction times, higher
product yields and conversions. More importantly, miniaturization ensures rapid mass

45

transfer thus providing high levels of control over reaction conditions [24-28]. State-ofthe-art developments in the design, fabrication and utilization of microfluidic devices
have found many applications in pharmaceutical, biotechnology and chemical industries
[24, 26]. Microfluidics has been shown as an effective technique to synthesize inorganic
nanocrystals [29, 30], however there is no reports found on nanosizing of ginseng PS.

Although ginseng PS have been shown to provide various immunomodulatory functions,
nanosized ginseng PS have not been investigated. For the first time, we have synthesized
ginseng PS NPs in a controllable fashion by using a continuous flow microfluidic device
and compared the NPs to other conventional wet chemical processes including
nanoprecipitation and the reverse microemulsion technique. The biological activity of
these PS NPs was investigated on Murine macrophage cell lines for the production of
nitric oxide, tumor necrosis factor-α, interleukin-1β and 6 cytokines.

2.2 Experimental
2.2.1 Materials

RAW 264.7 murine macrophage cell lines were used for all biological studies and carried
out in Prof Ed Lui’s Lab (Department of Physiology and Pharmacology, University of
Western Ontario, Canada). Cell culture medium and reagents were purchased from
Gibco laboratories (USA), BD OptEIA ELISA kits tumor necrosis factor-α, interleukin1,6 and 10 from BD Biosciences (USA). LPS from Escherichia coli (0111:B4), Griess
reagent, acetone, triton-X 100, and cyclohexane were purchased from Sigma-Aldrich
(Canada).

2.2.2 Isolation of ginseng PS from North American ginseng
1 g of ground ginseng root was soaked in 50 mL of purified water in a 100 mL beaker at
40 oC for 2 h. After extraction, the solution was filtered at room temperature and the
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extraction process was repeated three times. The three extracted portions were combined
and concentrated by a rotary evaporator (Buchi) under vacuum at 45°C until the total
amounts obtained were about 50%. These concentrates were lyophilized with a freeze
dryer (Labconco).

A solution of aqueous extract ginseng was prepared in distilled water (1g/mL) and the PS
fraction was precipitated by the addition of four volumes of 95% ethanol. The PS fraction
was collected by centrifugation at 4000 rpm for 10 min and lyophilized with a freeze
dryer to obtain crude ginseng PS. The crude portion (1 g) was further dissolved in 30 mL
water and partitioned five times with Sevag reagent (1:4 n-butanol:choloform, v/v, 100
mL each) to remove protein. The extract was precipitated again by 95% ethanol and
lyophilized to obtain dried ginseng PS.

2.2.3 Synthesis of PS NPs by precipitation method
5 mg of ginseng PS was dissolved in 5 mL water at 40 °C. Then 100 mL of acetone as an
anti-solvent was added dropwise under vigorous stirring. The freshly formed NPs were
then collected by centrifugation at 4500 rpm, washed with acetone and water (1:1) and
dried by using a freeze dryer.

2.2.4 Synthesis of PS NPs by water-in-oil microemulsion method
A homogeneous mixture of surfactant in oil phase was prepared by adding 1.8 mL of
Triton X-100 (surfactant), and 10 mL of cyclohexane (oil). 1 mL of ginseng PS aqueous
solution was then added to the microemulsion. The reaction mixture was stirred at room
temperature for 24 h. To separate and purify the desired nanoparticles, 25-30 mL of
acetone was added to break the emulsion and followed by sonicating and centrifuging.
Finally, the resultant NPs were washed 3-5 times with acetone and water. The samples
were then dried by using a freeze dryer at -50 oC under reduced pressure to produce PS in
a powdered form.
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2.2.5 Preparation of monodispersed PS NPs by capillary microfluidic
system
A T-junction microfluidics system was used based on nanoprecipitation mechanism as
outlined in Scheme 2.1. The system contains two infusion syringe pumps from KD
Scientific, pump 1 (Legato 2200) was used for pumping the aqueous solution of
polysaccharide and pump 2 (Legato 1100) was used for pumping acetone, used as an
anti-solvent, here we term the continuous phase. A PEEK stainless steel Micro-TEE of
1500 µm inner diameter and peek tubing with inner diameter of 75 microns and outer
diameter of 1500 µm were purchased from Upchurch Scientific. The Micro TEE was
placed vertically, as shown in Scheme 2.1. The continuous phase flow containing acetone
was pumped into the side arm of the Micro-TEE using an infusion multiple syringe
pump, while the aq. solution of ginseng polysaccharide solution was introduced to the top
arm of the Micro-TEE by an infusion pump with each inlet equipped with a check valve
to minimize the chance of back flow to the system. The formed nanoparticles were then
directed into a 5 ml reservoir solution containing acetone, placed directly underneath the
Micro-TEE at room temperature. Finally, the formed nanoparticles were collected by
centrifugation at 4500 rpm for 10 min and dried by using a freeze dryer overnight.

2.2.6 Nanoparticles characterization
The morphologies of the samples were examined using Scanning Electron Microscopy
(SEM) (Model LEO 1540XB FIB/SEM) and Transmission Electron Microscopy (TEM)
(Philips CM10). Samples for SEM imaging were prepared by applying the powder
directly to a carbon adhesive tape and coating with a thin layer of osmium in a vacuum
chamber. The TEM samples were prepared by depositing the NP suspension onto carbon
film coated copper grids. The size distribution of the NPs was assessed by DLS using a
Malvern Zetasizer Nano ZS® instrument, (Nano S model ZEN 1600, Malver, Orsay,
France) at room temperature. FTIR spectra of ginseng polysaccharide were obtained
using a using a Thermo Scientific Smart iTR with Diamond ATR Crystal at room
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temperature and OMNIC software at a resolution of 4 cm-1 and 128 scans. X-ray
diffraction (XRD) of the polysaccharide NP crystallinity was obtained with a Bruker D2
Phaser bench-top X-ray powder diffractometer using Cu Kα radiation (λ for Kα=1.54059
Å) at 30 kV and 10 mA. Dry powder samples were used with patterns collected in stepscan mode with a small grazing angle of incident X-ray with a 2θ scan range of 10-80 and
a step size of 0.25.

Scheme 2.1. Schematic of experimental set-up for the preparation of ginseng
polysaccharide nanoparticles by microfluidic system (pump 1: aqueous polysaccharide;
pump 2: acetone flow as an anti-solvent phase).

2.2.7 Cell culture
Macrophage cell line (RAW264.7) was cultured in Dulbeccos Modified Eagle’s Medium
supplemented with 10% Fetal Bovine Serum, 25 mM Glutamine, 100 IU/mL penicillin
and 100 µg/mL streptomycin. Cells were seeded in 96-well tissue culture plates at a
density of 1.5x105 cells per well and maintained at 37oC in a humidified incubator with
5% CO2.
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2.2.8 Immuno-stimulatory effect
To evaluate the dose-related stimulation of inflammatory mediators, an in vitro study was
carried out by treating and incubating macrophages with 0, 25, 50 and 200 μg/mL of bulk
and all types of ginseng polysaccharide NPs or 1 μg/mL of LPS (positive control) for 24
h. Then, quantification of inflammatory mediators, nitric oxide (NO), tumour necrosis
factor-α (TNF-α) and interleukin-6 (IL-6) was carried out to investigate the
immunostimulating effect of PS.

2.2.9 Nitric oxide assay
Nitric oxide production was analyzed by the accumulation of nitric oxide in a cell culture
medium. Nitric oxide in culture supernatants was determined with Griess reagent (SigmaAldrich, USA). Briefly, 50 µL of culture supernatant from each sample was transferred to
wells of a 96-well U-bottom microtiter plate, 50 µL of Griess reagent (containing 0.5%
sulfanilic acid, 0.002% N-1-naphtyl-ethylenediamine dihydrochloride and 14% glacial
acetic acid) was then added. The absorbance at 550 nm wavelength was measured using
Multiscan Spectrum microplate reader (Thermo Fisher Scientific, Finland). Nitric oxide
concentrations in samples were estimated from standard curve prepared using sodium
nitrite.

2.2.10 Quantification of interleukin-1β (IL-1β), interleukin-6 (IL-6), and
tumour nacrosis factor-α (TNF-α) assay

IL-1β, IL-6 and TNF-α pro-inflammatory mediators were measured in culture
supernatants with a solid phase enzyme-linked immunosorbant assay (ELISA) (BD
OptEIATM) employing the multiple antibody sandwich principle [31]. Culture
supernatants were added to each well of 96-well microtiter plates, precoated with
polyclonal antibody specific for the investigated mediators IL-1β,6, and TNF-α, then
incubated for 2 h at room temperature. After washing away (5 times) unbounded
substances, the culture was incubated for an additional 2 hours with polyclonal anti50

murine IL-1β, IL-6 and TNF antibody conjugated to horseradish peroxidase. After
washing (7 times) to remove any unbound antibody-enzyme reagent, tetramethyl
benzidine was added as a peroxidase substrate and the reaction was stopped after 30 min.
Absorbance was collected at 450 nm using an automated Spectra Count microplate reader
(Packard Instrument Co., Meridan CT).

2.3 Results and discussion
2.3.1 Morphology and size distribution of PS NPs
The size and monodispersity of NPs plays an important role for efficient drug delivery
through the gastrointestinal and other physiological barriers [18]. Both SEM and TEM
were used to determine the particle size and size distribution of ginseng PS. Figure 2.1(a)
represents the SEM image of PS before nanosizing. From this image, it is clearly
observed that there is no uniformity in the morphology of PS, which are completely
irregular shaped and large sized. Without further processing, the irregular size and shaped
ginseng PS are highly undesirable for controlled drug delivery applications. For
preliminary screening, the nanosizing of ginseng PS extract was carried out both by
precipitation and reverse microemulsion methods. In the case of nanoprecipitation, it is a
rather simple processing method for the fabrication of polymeric NPs e.g. PLGA, PLA
[32-34]. As seen in Figure 2.1(b-c), SEM images demonstrated the formation of NPs but
it was very difficult to estimate the exact size and size distribution from these images due
to the non-conductivity of PS under the utilized high voltage environment. To overcome
this, samples were further analyzed using TEM with Figure 2.1(d-e) revealing the
formation of separated NPs. In both cases, size distribution was estimated from these
TEM images by using ‘ImageJ’ software.
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Figure 2.1. SEM image of (a) as-extracted ginseng PS; (b) ginseng PS NPs prepared by
precipitation method; (c) ginseng PS NPs prepared by reverse microemulsion method;
TEM images and size distribution of ginseng PS NPs prepared by (d) precipitation
method, and (e) reverse microemulsion method.

In the precipitation method, ginseng PS were precipitated as nanoscale particles after
exposure to a non-solvent (acetone) that is miscible with the solvent (water). But in such
a process, it is always difficult to add acetone in a controlled manner, leading to the
formation of a wide size distribution. Here the size distribution was observed from 5-100
nm with an average size of 65 nm. In the next procedure, this problem was significantly
minimized by using the reverse microemulsion technique for the preparation of ginseng
PS particles. As the surfactant helps to keep the NPs separated from each other, a better
size distribution was observed compared to that prepared by the nanoprecipitation
method. Here, the NPs were obtained in the size range from 10 to 80 nm with an average
size of 50 nm (Figure 2.1). With this method, the major challenge is the complex washing
steps to remove both the surfactant and oil phases [23]. It also includes many steps, the
need to control the aqueous solution and reagent addition rates.
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Inspired by Prof. Langers work [27], we synthesized ginseng PS NPs in a microfluidic
channel using aqueous solution of PS and acetone as anti-solvent in a controlled
nanoprecipitation process. The rapid and continuous microfluidic process was carried out
at ambient temperature and atmospheric pressure, based on the nanoprecipitation concept
of particle formation examined in the batch process. In this study, the aim was to prepare
narrow size distribution ginseng PS NPs by varying the total flowrate ratios of solvent
and anti-solvent.

The flowrate ratio of the solvent and antisolvent phase has a significant effect on the
formation of nanoparticles. To study the effect of these ratios on particle size, three ratios
of solvent and antisolvent (1:10, 1:15, and 1:20) were maintained in the microfluidic
synthesis, with the particles size distribution measured using DLS. Figure 2.2 shows that
increasing the PS aqueous solution flow rate from 0.001 to 0.01 mL/min led to blocking
of the inlet microchannel, preventing the formation of NPs. Also, when the PS aqueous
solution flow rate was higher than 0.01 mL/min or higher than the anti-solvent phase
flow rate, NPs were not formed. It was also observed that increasing the ratio of solventantisolvent improves the monodispersity of the ginseng PS NPs (Figure 2.2). The
narrowest size distribution was observed for the ratio 1:20 (Figure 2.2c). Further
increasing the amount of anti-solvent gave no significant change.

Figure 2.2(a- b)

represents the SEM and TEM images of PS NPs prepared by the microfluidic system
with the flowrate ratio of solvent and anti-solvent at 1:20. From these images, it is clear
that the NPs were formed with uniform spheres and smooth surfaces. From the ImageJ
particle size distribution chart (Figure 2.2d), it is seen that the NPs are in the range of 1530 nm, with an average size of 20 nm. The flowrate of antisolvent phase was also found
to provide a significant role on the size of PS NPs. Figure 2.2e provides the relationship
between the average NP size and the antisolvent flowrate. As the flowrate of continuous
phase increased from 0.08 ml/min to 0.2 mL/min, the average size of the formed NPs
decreased from 70 to 20 nm. However, by lowering the flowrate of the anti-solvent phase
to 0.05 mL/min, no NPs were formed. Therefore, our experimental results showed that
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Figure 2.2. Ginseng polysaccharides nanoparticles formation by microfluidic system: (a)
SEM image, (b) TEM image, (c) size distribution by DLS with changing solvent-anti
solvent ratio (i) batch process (nanoprecipitation), (ii) solvent and antisolvent ratio (1:10),
(iii) solvent and antisolvent ratio (1:15), (iv) solvent and antisolvent ratio (1:20) (d) size
distribution of TEM image (by ImageJ software) (e) Effect of anti-solvent phase flow rate
on the particle size formation with the constant value of solvent phase flowrate (0.01
mL/min).

the NPs size obtained with the microfluidic method are tunable by changing the flowrate
of solvent and anti-solvent and also their ratios.
The mechanism of PS NP formation using the microfluidic technique includes different
stages as shown schematically in Figure 2.3. In the first stage, nuclei consisting of several
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unimers are formed when the PS experience a change in solvent. In the second stage,
these nuclei grow in size through a diffusion-limited process by the addition of more
unimers. This process continues until the nanoparticles grow sufficiently large in size,
minimizing the addition of more unimers due to the formation of a polymer brush layer
on the NP surface. The end of the second stage results in so-called "kinetically locked"
NPs. The third stage is characterized by extremely slow changes in NP growth due to
exchange of unimers in order to reach equilibrium [27].

Figure 2.3. Mechanism of the formation of ginseng polysaccharide nanoparticles through
microfluidic device based on nanoprecipitation mechanism.

In order to better understand the effect of flowrate on the particle size, we need to
consider the Reynolds number (Re) and the capillary number (Ca). Typically, in a
microfluidic system, the fluid flow has a low value of Re, indicating laminar flow. In the
microfluidic system, if the flow rate of the solvent phase is higher than that of the antisolvent, droplets may become elongated, causing break- due to the pressure drop across
the droplet. However, when the solvent phase flow rate is lower than the anti-solvent
flow rate, insufficient time is available for elongation [35], as used in this study. Table
2.1 shows the values for Ca and Re numbers used in this work which were calculated
based on the utilized microfluidic system and the anti-solvent phase properties. The low
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values for the Re number confirms laminar flow. The results show that Ca is lower than
0.01, implying that the size of NPs are independent of Ca and are mainly determined by
the ratios of the solvent and anti-solvent phases flow rates [36].

Table 2.1. Values of capillary number (Ca) and Reynolds number (Re) with different antisolvent phase flowrate.

Solvent flow-rate
(mL/min)
0.01

Anti-solvent flow-rate Capillary number
(mL/min)
0.05
5.6x10-4

Reynolds number
13.7

0.01

0.08

9.0 x10-4

21.9

0.01

0.1

11.3 x10-4

27.4

0.01

0.15

16.9 x10-4

41.2

0.01

0.2

22.5 x10-4

54.9

2.3.2 Functionality of PS after NPs formation

Figure 2.4(a) shows the FTIR spectra of both the PS extracted from ginseng before
nanosizing and the resultant PS NPs. It is observed that the presence of functional groups
in both cases are the same, showing that microfluidic processing did not change the
chemical functionality of the PS. The contribution of the main absorption characteristics
of PS structures are related to O-H stretching between 3500 and 3000 cm-1, C-H
stretching between 3000 and 2800 cm-1, and C=O stretching between 1600 and 1700 cm1

. A peak between 1200 and 1000 cm-1 was found in association with the C-O-H and C-

O-C band positions. Additionally, both the as-extracted ginseng PS, and ginseng PS NPs
prepared by the microfluidic system were characterized using X-ray diffraction as shown
in Figure 2.4(b). The XRD pattern of PS extract shows a broad peak in the 20 to 40
degree region that is consistent with literature [37]. After NP formation, the peak in the
region 18 to 25 degree becomes sharp and more intense. This increase in crystallinity is
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attributed to enhanced order because of uniformity in size. This kind of behavior has been
reported previously for other polymers [38].

Figure 2.4. (a) FTIR spectra, and (b) XRD pattern of as-extracted ginseng
polysaccharides, and ginseng polysaccharide nanoparticles prepared by microfluidic
system (i) ginseng polysaccharide extract before nanosizing process, (ii) ginseng
polysaccharide nanoparticles.

2.3.3 Biological activities of PS NPs
In this work, we used Murine macrophage cell lines (RAW 264.7) to investigate the
immunomodulating behavior of ginseng PS. Macrophages are specialized leukocytes that
respond to invading pathogens by initiating phagocytosis and the synthesis and release of
pro-inflammatory cytokines. Microorganisms (bacteria, fungi, protozoa, viruses) have
pathogen-associated molecular patterns (PAMPs) that are identified by pattern
recognition receptors on macrophages. The left side of Figure 2.5 illustrates the process
of phagocytosis, which involves engulfment of pathogens into an intracellular vesicle
called a phagosome. Phagosomes then merge with lysosomes to form a phagolysosome,
where degradation of the pathogens occurs by enzymes, then cellular release of the
degraded material by exocytosis happens. The right side of Figure 2.5 illustrates that
pathogens binding to surface receptors of the macrophage also signal the transcription of
pro-inflammatory cytokines in the cell's nucleus. Cytokines are then produced in the
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cytoplasm and these pro-inflammatory proteins are secreted from the cell, which we
quantified during biological activities study [39, 40]. Because ginseng PS alter cytokine
production by macrophages, we first investigated whether bulk ginseng PS extract alters
cytokine production by macrophages and then compare with the nanosized PS.

Figure 2.5. The role of macrophage cell line in response to pathogen infection and then
production of pro-inflammatory cytokines.

As shown in Figure 2.6, murine macrophages were treated with 25, 50, 100 and 200
µg/mL of ginseng PS bulk and NPs prepared using the investigated techniques
(nanoprecipitation, microemulsion, and microfluidics) for 24 h. The culture supernatants
were used for quantification of the production of the reactive oxygen compound nitric
oxide and organic cytokines (TNF-α, IL-1β and IL-6) by macrophages. The results
reveal that stimulation of macrophages with PS for the production of NO, TNF-α and IL1β were significantly higher than cells without any treatment in the medium (Figure 2.6).
IL-6 was also significantly increased by exposure to ginseng PS NPs as compared to
control (cells in medium alone). Here, lipopolysaccharide (LPS) was used as the positive
control,
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Figure 2.6. Immunostimulatory effect of three different types of ginseng polysaccharides
nanoparticles prepared using (a) nanopreicipitation, (b) microemulsion, and (c)
microfluidic, on macrophage cell lines. Murine macrophages (RAW 264.7 cells) were
treated with four different concentration of ginseng PS NPs (25, 50, 100, 200 μg/mL),
LPS (1 μg/mL) for 24 h and the culture supernatants were analyzed for the production of
inflammatory mediators, (i) NO, (ii) TNF-α, (iii) IL-1β, and (iv) IL-6.

which is a structural component of the outer cell wall of gram negative bacteria and
produces a strong immune response in mammals [17]. Indeed, all types of ginseng PS
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NPs significantly up-regulated macrophage production of all inflammatory mediators
NO, TNF-α, IL-1β, and IL-6 compared to the untreated control in a dose-dependent
manner.

Compared to previous studies on the stimulation of macrophages by ginseng PS [17, 41],
our results with ginseng PS NPs show a significant stimulating enhancement. Figure
2.7(a) shows the nitric oxide production of bulk and the three investigated types of
ginseng PS NPs for a concentration of 25, 50, 100 and 200 µg/mL. Upon treatment with
bulk ginseng PS, macrophages produced low levels of nitric oxide and other cytokines.
On the other hand, NO production was similar to the maximum stimulatory response
induced by 1 μg/mL of LPS when the treated cells with 200 μg/mL of NPs were prepared
by the nanoprecipitation and microemulsion methods. But the maximum production
occurred, even higher than LPS with the treatment of PS NPs produced by microfluidic
system.

Figure 2.7. (a) NO production of Macrophage cell lines after treatment with bulk and
different nanosized ginseng polysaccharides at four different concentrations (25, 50,100,
200 µg/mL). LPS was used as positive control and cells without any treatment as
negative control. (b) Cytokines production of Macrophage cell lines after treatment with
bulk and different nanosized ginseng polysaccharides with a concentration 200 µg/mL
(The graph was drawn for better comparison; original data has shown in Figure 2.6).
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They produced higher amount of nitric oxide because of uniform sized particles. In
addition, all ginseng PS (bulk and NPs) (200 µg/mL) significantly increased the
production of cytokines (TNF-α, Il-1β and IL-6) from the investigated murine
macrophage cell lines (Figure 2.7b). These results reveal that ginseng PS NPs are more
effective immunostimulating agents compared to the bulk ones. Also, NPs prepared using
the microfluidic system were the best amongst the techniques investigated, attributed to
their smaller and more uniform size.
Activated macrophages not only participate in both specific immune reactions and nonspecific immune reactions, but they are also the “bridge cell” of these two kinds of
immune reactions. They have a relatively strong germicidal effect within the cells and a
neoplasia-dissolving effect outside the cell. These germicidal and neoplasia effects can
inhibit the growth and metastasis of tumor cells [42], directly killing them by secreting
cytotoxic molecules or indirectly by recruitment and activation of other immune cells in
relation to tumor suppression. Thus, effector molecules (NO and cytokines) produced by
the stimulated macrophages help to eliminate tumor cells. In the present study, the PS
from Panax ginseng was shown to stimulate murine macrophages, in agreement with the
mechanism(s) observed by many others [43]. These results suggest that ginseng PS NPs
treated macrophages exhibit a higher capacity to produce reactive oxygen compound
nitric oxide and organic cytokines compared to the bulk PS. Therefore, NA ginseng PS
NPs can be considered as a therapeutic agent against tumor or cancer cell.

2.4 Conclusions
This work shows that ginseng PS NPs can be prepared by various nanoprecipitation
methods, with microfluidics enabling narrow size distribution NPs. This microfluidic
system shows the advantages of ease of fabrication, simplicity, and a fast and low-cost
process that is capable of generating ginseng PS NPs with the average size of 20±4 nm.
All Ginseng PS NPs, especially particles prepared by microfluidic system significantly
upregulated the macrophage production of all investigated mediators in a dose dependant
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manner compared to the untreated control. Therefore, nanoprocessing of ginseng PS can
potentially enhance the immunostimulating properties of macrophage cell lines.
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Chapter 3

Biodistribution and immunomodulatory activity of
fluorescent labeled ginseng polysaccharide
nanoparticles
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Abstract
Polysaccharides are a major active component of North American ginseng (Panax
quinquefolius) root showing various biological activities including anti-carcinogenic,
anti-aging, immunostimulatory and antioxidant effects. Although their biological activity
has been reported by several groups, no research has explored their cellular uptake and
biodistribution, owing to the lack of suitable detection techniques in living cells. This
work examines a novel, simple and efficient procedure for the fluorescent labeling of
ginseng polysaccharides (PS), in order to examine their cellular distribution using
confocal laser scanning microscopy (CLSM). This procedure utilized a one-pot strategy
with fluorescein-5-thiosemicarbazide (FTSC) to introduce a thiosemicarbazide group
onto the aldehyde group at the reducing saccharide end to form a stable amino derivative
through

reductive

amination.

This

polysaccharide-FTSC

derivative

was

then

characterized by UV, FTIR, GPC, photoluminescence and fluorescence microscopy in
order to confirm attachment and any structural changes. The results demonstrated that the
labeled ginseng PS nanostructure showed high fluorescence with minimal changes in PS
molecular weight. The labeled PS exhibited almost no cytotoxicity effect against tumor
induced macrophage cell lines (RAW 264.7) while retaining high immunostimulating
activity similar to the non-labeled ginseng PS. Therefore, the developed approach
provides a convenient and highly efficient fluorescent labeling procedure for
understanding the mechanism of ginseng PS uptake in macrophage cell lines.

3.1 Introduction
Ginseng is a perennial herb of the genus Panax that belongs to the Araliaceae family [1].
The Panax species that are most widely used as medicinal herbs include Panax
quinquefolius L. (North American ginseng), Panax ginseng C. A. Mayer (Asian or
Korean ginseng), Panax japonicus (T. Nees) C. A. Mey. (Japanese ginseng), Panax
notoginseng (Burkill) F.H. Chen (PN, Sanchi ginseng) and Panax vietnamensis Ha &
Grushv (Vietnamese ginseng). North American (NA) ginseng is native to both Canada
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and eastern USA and has been recognized as a valuable ‘tonic’ similar to Asian ginseng
[1-7]. As one of the best-selling medicinal herbs in the world, NA ginseng is well
documented in the US Pharmacopeia (USP) and the China Pharmacopeia (CP) [1].
Recent studies indicate that ginsenosides, polysaccharides (PS), amino acids, vitamins,
and minerals are the major chemical components in ginseng showing pharmacological
activities including immunomodulation, anti-tumor, anti-adhesive, anti-oxidant and
hypoglycemic activities [4, 6, 8-12].

For example, COLD-FX® is a commercially

available product of poly-furanosyl-pyranosyl-saccharides from NA ginseng root, and has
been clinically used for the prevention of upper respiratory tract infections [6, 13].

To date, fluorescence based techniques have been greatly encouraged in bioimaging due
to their inherent advantages, such as high sensitivity, high selectivity, convenience and
non-invasive character [14-16]. For examining the in vitro and in vivo biodistribution
response of PS, it is necessary to follow their cellular uptake and endocytosis. The
internalization and penetration of the cells and tissues by PS can be efficiently monitored
by fluorescent microscopy, if the PS is tagged with a stable fluorescent marker [17].
Covalently bound fluorescent labels can offer a promising tool to obtain highly stable
fluorescently labeled particles for an appreciable period of time [18-20]. Currently, no
reported literature has examined the fluorescent labeling of ginseng PS and the tracking
of cellular internalization. Thus, chemical derivatization of ginseng PS with fluorescent
tags can make intracellular microscopic inspection possible.

Recently, confocal laser scanning microscopy (CLSM) has become an effective
microscopic tool that provides valuable morphological and functional information on the
cells and tissues [18]. A successful utilization and interpretation of CLSM depends on
several experimental parameters including excitation and emission wavelength,
fluorescence intensity, lifetime and stability of the fluorescent label material [18, 21].
However, leakage of the fluorescent label from the matrix makes it very difficult to locate
the signal from PS. Therefore, a stable fluorescent label is of crucial importance for the
sensitivity of quantitative and qualitative detection for the successful contrast required for
CLSM imaging.
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The presence of various functional groups in PS allows for their modification and finetuning of properties for biomedical applications. Consequently, several methods have
been developed for the modification and derivatization of PS using their lateral functional
groups (e.g. -OH, -COOH, -CHO) to perform etherification, esterification, amidation,
sulphation, reduction amination [22]. The most commonly used technique for the
fluorescent labeling of saccharides is the reductive amination-based method, which
introduces an aromatic amine to the aldehyde group at the reducing end of saccharides
[23, 24]. Many researchers have examined and reported on different fluorescent organic
dyes

as

markers,

including

rhodamine

110,

O-2-aminoethyl

fluorescein,

5-

aminofluorescein, and 8-aminonaphthalene-1,3,6-trisulfonate [25-28]. But low quantum
yield and poor photostability often pose a problem for these dyes, especially during
fluorescence microscopic analysis [23]. Recently, intensive efforts have been undertaken
to covalently link fluoresceinamine, fluorescein isothiocyanate (FITC), lissamine
rhodamine B sulfonyl chloride (LRSC) with saccharides [20, 29-31]. However, low yield,
too many reaction steps, pH dependence, complex reaction procedures and long reaction
time limit their convenience for labeling of saccharides [23]. In addition, fluorescein-5thiosemicarbazide (FTSC) is another fluorescent labeling agent which has been used as a
marker to label polymers [23, 32, 33]. The results showed FTSC has potent fluorescence
intensity and intrinsic reactivity of its thiosemicarbazide group onto the aldehyde group
of the polymers. FTSC has also proven to be friendly to living cells and compatible with
the argon laser coupled to fluorescent instruments. It is anticipated that FTSC can be
linked with ginseng PS and the activity and stability of the labeled PS can be monitored.
Notably, there is no report published on fluorescent labeling of ginseng PS with a
fluorescent dye for confocal microscopy analysis.

Recently, we have shown that ginseng PS nanoparticles (NPs) synthesized using a
microfluidic system have higher immunostimulation compared to the bulk ginseng PS
[34]. Others also have shown the immunostimulating properties of bulk ginseng PS [35,
36]. However, due to the absence of any fluorescent groups in the ginseng PS, it is not
possible to monitor the transport of PS inside the cells. Therefore, for the first time, we
have developed a facile procedure for the fluorescent labeling of ginseng PS NPs using
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fluorescein-5-thio semicarbazide as a fluorescent dye. The FTSC labeled product was
further characterized by UV, FTIR, GPC, DLS, PL spectroscopy to investigate the
attachment and any effect on ginseng PS. The cell uptake studies were carried out using
Macrophage cell lines (RAW264.7) by inverted confocal microscopy to examine the dye
uptake time. Furthermore, the cytotoxicity and the immunostimulating property of
labeled ginseng PS NPs was examined and evaluated against the living cells.

3.2. Experimental
3.2.1 Materials
North American ginseng (Panax quinquefolius) roots were collected from Delhi, Ontario,
and provided by Dr. Dan Brown, Principal Investigator, Bioactives Research, Canadian
Centre for Agri-food Research in Health and Medicine. A reference plant was deposited
in University of Western Ontario, Department of Biology Herbarium (entry number
52100). The dried root samples were ground in liquid nitrogen. Fluorescence 5-thio
semicarbazide (FTSC), dimethyl sulfoxide (DMSO), glacial acetic acid (HAc), sodium
cyanoborohydride (NaBH3CN), were purchased from Sigma Aldrich (Canada). RAW
264.7 (ATCC TIB 67) murine macrophage cell lines were used for all biological studies
and carried out in Professor Lui’s Lab (Department of Physiology and Pharmacology,
University of Western Ontario, Canada). Purified LPS from Escherichia coli serotype
0111:B4, Griess reagent were purchased from Sigma Aldrich (Canada). Cell culture
medium and reagents were purchased from Gibco laboratories (USA), BD Opt EIA
ELISA kits tumor necrosis factor-α, interleukin-1,6 and 10 from BD Biosciences (USA).

3.2.2 Extraction of ginseng PS
Ginseng PS used in this study was extracted from NA ginseng root as described in our
previous work [34, 35]. Briefly, ground ginseng root (4 g) was immersed in 200 mL of
deionized water at 40°C for 2 h. After extraction, the solution was filtered at room
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temperature and the extracted portions were concentrated by a rotary evaporator (Buchi)
under vacuum at 45°C. These concentrates were lyophilized with a freeze dryer
(Labconco). One gram of aqueous extract ginseng was dissolved in 1 mL of deionized
water. The PS fraction was precipitated from the solution by the addition of 4 mL of
ethanol. The PS portion was collected by centrifugation at 4000 rpm for 10 min and
lyophilized with a freeze dryer to obtain crude ginseng PS. One gram of crude PS was
further dissolved in 30 mL of water and partitioned with Sevag reagent (1:4 nbutanol:choloform, v/v, 100 mL each) to remove the protein. Finally, the extract was
precipitated using 95% ethanol and lyophilized to obtain dried ginseng PS (Scheme 3.1step 1).

3.2.3 Synthesis of ginseng PS NPs
Monodispersed ginseng PS NPs were prepared by a T-junction capillary microfluidics
system, as we reported previously [34].

The formation of NPs followed the

nanoprecipitation mechanism under a controlled interaction with solvent and anti-solvent.
Aqueous solution of PS was passed through an infusion syringe pump while other syringe
pumped acetone, used as an anti-solvent. Here, we used the optimized flowrates of
aqueous solution of ginseng PS and anti-solvent that showed the best monodispersity of
NPs [34]. These flowrates were 0.01 mL/min and 0.2 mL/min respectively. The formed
NPs were then directed into a 5 mL reservoir solution containing acetone, placed directly
underneath the Micro-TEE at room temperature. Finally, the formed NPs were collected
by centrifugation at 4500 rpm for 10 min and dried by using a freeze dryer for overnight
(Scheme 3.1-step 2).

3.2.4 Labeling of PS with FTSC
Sodium cyanoborohydride (300 mg) was added in a mixture of dimethyl sulphoxide (8.4
mL) and glacial acetic acid (3.6 mL). The reactant mixture was stirred for 30 min at room
temperature. Ginseng PS NPs (140 mg) and FTSC dye (70 mg) was added to the sodium
borohydride cyanide solution. The mixture was stirred for 4 h at 400 rpm at room
temperature. Then the reaction was continued at 75oC for 8 h. The yellow colored product
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was collected by centrifugation at 4000 rpm for 10 min and washed with deionized
distilled water to remove any free dye. The final yellow product was lyophilized using a
freeze dryer at -50oC under reduced pressure to produce labeled PS NPs as powdered
form (Scheme 3.1-step 3).

extraction with
extraction
Sevag reagent
Water soluble with ethanol crude ginseng
ginseng root
polysaccharide
extract

extraction
with water

Step 1

ginseng
PS (bulk)

NA ginseng
root
nanosizing
processing

Step 2

pump1: PS solution

ginseng
PS NPs

pump2: continuous phase

ginseng
PS (bulk)

microfluidics

Step 3
O
OH

O

HO
OH

+

O

O
HO

HO

H

NH

NH

C
NH

OH

OH

NH

OH

OR

S

Saccharide

OH

C

N

NH

OH

OR

C

HO

S

HO

OH

H

H

C

N

C
NH

H

H

fluorescene
5-thio semicarbazide

labeled ginseng
PS NPs

Step 4
treatment with
O

OH

O
O

HO

50 m

macrophage
cell lines

OH
OR
HO

50 m
NH

OH H
C
H
C N NH S
OH
H

macrophage cell lines after treatment
with labeled ginseng PS NPs
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3.2.5 Nanomaterials characterization
The morphologies of the PS NPs samples were examined using Transmission Electron
Microscopy (TEM) (Philips CM10). Samples were prepared by depositing the NP
suspension on carbon film coated copper grids. The size distribution of the NPs was
assessed by Dynamic Light Scattering (DLS) using a Malvern Zetasizer Nano ZS®
instrument, (Nano S model ZEN 1600, Malver, Orsay, France) at room temperature.
Fourier Transformed Infrared (FTIR) spectra of the non-labeled, labeled ginseng PS NPs
and pure dye (FTSC) were obtained using a Thermo Scientific Smart iTR with Diamond
ATR crystal at room temperature and OMNIC software at a resolution of 4 cm-1 and 128
scans. A Shimadzu UV-3600 UV-vis spectrophotometer was used to measure the
absorption spectra of the non-labeled ginseng PS NPs, labeled ginseng PS NPs and
FTSC. The samples were prepared by dispersing them in MilliQ (EMD Milli pore) water.
A PTI photoluminescence (PL) spectrophotometer was used to measure the PL emissions
of labeled ginseng PS NPs and FTSC. Labeled and non-labeled ginseng PS NPs were
analysed at 40°C with PAA-200 Series column (8×300 mm, Poly Analytik, USA)
connected to a Viscotek (Varian Instruments, USA) gel permeation chromatography
system with Omnisec software (version 4.5, Viscotek, USA) for data acquisition.
Aqueous solutions of labeled and non-labeled PS (2 mg/mL) were filtered with 0.2 μm
nylon filter and used for analysis. Each sample (100 μL) was injected and eluted with
0.05M sodium nitrate (NaNO3) mobile phase at a flow rate of 1 mL/min and monitored
using a multiple detectors system for light scattering, refractive index and viscosity.
Pullulan PS reference standard was analyzed as a positive control.

3.2.6 Cell culture and imaging
Murine Macrophage cell line (RAW264.7) was cultured in RPMI (Roswell Park
Memorial Institute medium) medium supplemented with 10% Fetal Bovine serum, 25
mM HEPES, 2mM Glutamine, 100 IU/mL penicillin and 100 µg/mL streptomycin. Cells
were seeded in 96-well tissue culture plates at a density of 2x105 cells per well and
maintained at 37oC in a humidified incubator with 5% CO2. A ZEISS LSM 5 Duo
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confocal microscope was used to take the fluorescence images of the labeled ginseng PS
NPs treated macrophage cell lines using an argon laser at 488 nm and magnification 20x.
Murine macrophage cell lines were treated with 200 µg/mL of labeled PS NPs and
incubated for 24 h. Cells were washed extensively with Phosphate buffer saline (PBS)
before confocal analysis of the investigated cell lines.

3.2.7 MTT assay and cell viability
Cell

viability

was

evaluated

with

the

3-(4,5-dimethylthiazol-2-yl)-2,5-

diphenyltetrazolium bromide (MTT) assay. Briefly, macrophage cell lines were incubated
in a 96-well plate and maintained in the growth medium for 24 h at 37oC. After 24 h the
culture medium was removed; 150 μL MTT solution (0.5 mg/mL) was added to each well
and incubated for another 4 h. Then, the medium was carefully removed from the plate,
and DMSO was added to solubilise formazan produced from MTT by the viable cells.
The amount of viable cells in each well was determined by the absorbance of solubilised
formazan. Absorbance was measured at 540 nm using a microplate reader.

3.2.8 Immuno-stimulatory effect
Macrophages were treated with 0, 25, 50, 100 and 200 μg/mL (RAW 264.7 cell line) of
non-labeled and labeled ginseng PS NPs or 1 μg/mL of LPS (positive control) for 24 h,
maintained at 37°C in a humidified incubator with 5% CO2. Aliquots of culture medium
were collected and frozen at -20 °C until ready for nitric oxide (NO), tumour necrosis
factor-α (TNF-α), interleukin-1β and interleukin-6 (IL-6) analysis. The experiments were
performed in triplicate on three independent occasions.

3.2.9 Nitric oxide assay
Nitric oxide production was analyzed by the accumulation of nitric oxide in a cell culture
medium. Nitric oxide in culture supernatants was determined using Griess reagent (0.5%
sulfanilic acid, 0.002% N-1-naphtylethylenediamine dihydrochloride, 14% glacial acetic
acid). Culture supernatant (50 µL) from each sample and the Griess reagent (50 μL) were
added to a 96 well plate and kept in dark for 30 min. Finally, the absorbance of the red75

pink colored product was measured at 550 nm wavelength using a Multiscan Spectrum
microplate reader (Thermo Fisher Scientific, Finland) with SkanIt software (version
2.4.2, Thermo Fisher Scientific, Finland). Nitric oxide concentrations in samples were
estimated from a standard curve prepared using sodium nitrite.

3.2.10 Quantification of interleukin-1β (IL-1β), interleukin-6(IL-6), and
tumour necrosis factor-α (TNF-α) assay
IL-1β, IL-6 and TNF-α concentrations in supernatants from cultured cells were measured
with a solid phase enzyme-linked immunosorbant assay (ELISA) (BD OptEIATM)
employing the multiple antibody sandwich principle [37]. Culture supernatants were
added to the 96-well microtiter plates, which was precoated with polyclonal antibody
specific for the investigated mediators IL-1β, 6, TNF-α and incubated for 2 h at room
temperature. After washing with PBS, the culture was incubated for another 2 h with
polyclonal anti-murine IL-1β, IL-6 and TNF antibody conjugated to horseradish
peroxidase. After the washing step, tetramethylbenzidine was added as a peroxidase
substrate after 30 min to stop the reaction. Absorbance was measured at 450 nm using a
Multiscan Spectrum microplate reader (Thermo Fisher Scientific, Finland) with SkanIt
software (version 2.4.2, Thermo Fisher Scientific, Finland).

3.3 Results and discussion
3.3.1 Morphology and size distribution of ginseng PS NPs
Our previous methodology was utilized for preparing ginseng PS NPs of controlled
dimensions for the present study. This corresponds to step 1 and 2 in Scheme 1. TEM and
DLS were used to determine the particle size and size distribution of ginseng PS NPs
prepared by the microfluidic system. From the TEM image (Figure 3.1a), it is clearly
observed that NPs were formed from the extracted PS with uniform spheres and smooth
surfaces. From the DLS result (Figure 3.1b), it is seen that the NPs are in the range of
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15-30 nm, with an average size of 20 nm. These prepared uniform size and shaped
particles are suitable for our investigation on dye labeling and cellular distribution.
Monodispersed polymeric NPs can be effective in passing through the mucus barrier as
reported previously [38, 39].

Figure 3.1. (a) TEM image of ginseng PS NPs prepared by microfluidic system; and (b)
size distribution of ginseng polysaccharides nanoparticles measured by DLS.

3.3.2 Optical properties and structural characteristics of fluorescent
labeled PS NPs
The fluorescence intensity of the PS NPs, pure dye (FTSC) and dye labeled PS NPs were
measured using PL spectroscopy. With an excitation wavelength of 494 nm, the emission
spectra of the pure FTSC was observed at 518 nm (Figure 3.2a(i)) which matches with
reported literature [23]. The presence of PS with dye does not change the fluorescent
property of the conjugated molecules, but introduces some subtle differences, as observed
from Figure 3.2a (ii). With the same excitation wavelength 494 nm, the emission spectra
of dye labeled PS gives an emission peak at 525 nm. There is an approximate 7 nm red
shift compared to that of the pure FTSC dye which we attribute to the larger particle size
from chemical linking between the FTSC dye and polysaccharide. A similar red shift was
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reported for fluorescent dye conjugation with other types of polymer [40]. There was no
peak observed in case of non-labeled PS NPs (Figure 3. 2a (iii)).

Figure 3.2(b) shows the FTIR spectra of pure FTSC, ginseng PS NPs and the FTSC
labeled PS NPs. FTIR spectrum of ginseng PS NPs (Figure 3.2b(iii)) showed a typical
absorption peak for O-H stretching between 3500 and 3000 cm-1, C-H stretching between
3000 and 2800 cm-1, and C=O stretching at 1600 cm-1. A peak at 1000 cm-1 was found in
association with a C-O-C bond. Again, the FTIR spectrum of pure dye (FTSC) (Figure
3.2b (i)) showed the characteristics peaks of N-H stretching between 3000-3200 cm-1, and
C-N stretching between 1500-1570 cm-1. Furthermore, the FTIR spectrum of FTSC
labeled PS (Figure 3.2b (ii)) showed the characteristic peaks of PS at ~3190cm-1 (for OH), at ~2900 cm-1 (for C-H) and at ~1000 cm-1 for an ether bond. It also showed the
characteristics peak for pure dye between 1500-1570 cm-1 (for C-N stretching) and at
1530 cm-1 assigned to the imine group that is formed during conjugation (Scheme 3.1,
step 3). Therefore, all of these spectra confirmed the presence of dye within the
polysaccharide structure.

Figure 3.2. (a) Photoluminescence spectra and (b) FTIR spectra of (i) Pure dye (FTSC),
(ii) Dye labeled ginseng polysaccharides nanoparticles, and (iii) ginseng polysaccharides
nanoparticles.
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The FTSC content of the labeled PS was determined by UV-Vis spectroscopy. Figure
3.3a compares the UV-Vis absorption spectrum of FTSC-labeled PS NPs with the spectra
of ginseng PS NPs (without labeling) and pure FTSC dye in solution. Unlabeled PS NPs
showed no absorption peak in the visible wavelength range of 400 to 800 nm. An
absorption maximum peak at 264 nm is observed, whereas pure FTSC dye and FTSClabeled PS NPs showed the peaks at 490 nm and 464 nm respectively.

The labeled and non-labeled ginseng PS NPs were further analyzed by GPC with
multiple detectors (refractive index, right angle light scattering, lower angle light
scattering and viscometer detectors). Chromatographic analysis with the right angle light
scattering detector gave the best qualitative and specific detection in identifying the
labeled and non-labeled ginseng PS NPs. Pullulan PS (Mp = 212000, 112000, 11800,
2150 Da) was used as a comparable reference standard. The calibration curve was
prepared based on the dependence of log molar mass (M) versus retention volume
[insight of Figure 3.3b]. Right angle light scattering data in Figure 3.3b shows the
retention volume peak of non-labeled ginseng PS NPs at 21.5 mL and for labeled ginseng
PS NPs at 21 mL. The retention volume peak has shifted to the high molecular weight
region after conjugation of FTSC dye with ginseng polysaccharide [reaction in Scheme
3.1: step 3].

Figure 3.3. (a) UV/visible absorption spectra of an aqueous suspension of (i) pure FTSC
dye (ii) FTSC-labeled polysaccharides nanoparticles and (iii) ginseng polysaccharides
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nanoparticles (without labeling); (b) Gel permeation chromatograms using right angle
scattering detector (i) ginseng polysaccharides nanoparticles (without labeling) and (ii)
FTSC-labeled ginseng polysaccharides nanoparticles.

3.3.3 Cell viability and cytokines assay
Previously, we found a strong immune responsive effect on the murine macrophage cell
line RAW264.7 (abelson murine leukemia virus induced tumor cell line) using a
bioassay, although no labeling or imaging studies were carried out [34]. In this work,
dye-labeled ginseng PS was synthesized to monitor the transport of PS inside cell lines,
so it is important to examine the cytotoxicity of the labeled PS and then compare with the
non-labeled PS. Cell viability was evaluated with the 3-(4,5-dimethylthiazol-2-yl)-2,5diphenyltetrazolium bromide (MTT) assay. Figure 3.4 represents the cell viability study
that was carried out using MTT assay. In the case of ginseng PS NPs (without labeling),
there is no difference in cell viability compared to the control over the examined
concentration range (Figure 3.4a). On the other hand, MTT assay indicates that labeled
ginseng PS did not affect the cell viability at concentration 200 µg/mL or lower (Figure
3.4b). At very high concentration (2000 µg/mL), less than 4% cells were damaged
compare to the control group. Therefore, FTSC labeled PS exhibited almost no
cytotoxicity against macrophage cell lines which illustrates its potential application in
living cells.
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Figure 3.4. MTT assay of (a) ginseng PS NPs and (b) labeled ginseng polysaccharides
nanoparticles to evaluate the cell viability.

Ginseng PS is known to have immune-stimulatory effects on macrophage cell lines [34,
35, 41]. So, it is important to examine the changes of this property after labeling of
ginseng PS or ginseng PS NPs. Macrophage cell lines RAW264.7 were used to
investigate the immunostimulatory property of labeled and non-labeled ginseng PS NPs
by measuring the production of proinflammatory mediators (e.g., NO, TNF-α, IL-1β, IL6). As shown in Figure 3.5, murine macrophages were treated with 25, 50, 100 and 200
µg/mL of labeled and non-labeled ginseng PS NPs. The culture supernatants were used
for the quantification of the production of proinflammatory mediators. We used LPS
(lipo-polysaccharides) as a positive control and the macrophage cell line without any
treatment as the negative control. The results reveal that stimulation of macrophages with
labeled and non-labeled PS NPs for the production of inflammatory mediators is
significantly higher than the untreated control. All the particles upregulated macrophage
production for all investigated mediators in a dose-dependent manner. Moreover,
maximum NO, TNF-α and IL-1β production was observed using 200 µg/mL of labeled
and non-labeled PS NPs which was even higher than LPS treatment (Figure 3.5 a-c).
Labeled ginseng PS NPs were able to produce all investigated mediators (NO, TNF-α,
IL-1β), similar to the unlabeled PS. The only difference noted was a ~4% lower IL-6
production with the labeled ginseng PS NPs compared to the non-labeled one. Therefore,
the labeling procedure did not diminish the ‘stimulatory’ property of ginseng PS.
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Figure 3.5. Immunostimatory effect of labeled and non-labeled ginseng polysaccharides
nanoparticles. Murine macrophages (RAW 264.7 cells) were treated with four different
concentration of ginseng polysaccharides (25, 50, 100, 200 μg/mL), LPS (1 μg/mL) for
24 h and the culture supernatants were analyzed for the production of inflammatory
mediators, (a) NO, (b) IL-1β, (c) TNF-α, and (d) IL-6.

3.3.4 Macrophage internalization of fluorescent labeled PS NPs and
CLSM imaging

A major advantage of fluorescent labeling technique is that the labeled product can be
used to monitor the transport and action of target molecules within living cells [23]. In
order to investigate the cellular uptake behavior of dye labeled PS as a function of time,
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we used inverted confocal microscope with three contrast modes (dark, bright and
merge). Hence, macrophage cell lines were treated with 200 µg/mL of labeled PS NPs
and then investigated after each 30 min up to 6 hr, then after 24 hr and 48 hr of treatment.
From the confocal images (Figure 3.6 a-b), it was observed that at 0 and 2 h there is no
fluorescence signal, indicating no cellular uptake of the dye labeled PS. However, at 4 h
of further incubation, a green fluorescence signal was observed indicating that cellular
uptake begins (Figure 3.6c). After 6 h of treatment, the fluorescence signals were more
intense, indicating enhanced dye labeled PS NPs uptaken by the cells (Figure 3.6d). After
24 h of treatment, almost all of the cells uptake dye labeled PS NPs (Figure 3.6e).
Furthermore, at 48 h of further incubation, the fluorescence signal was observed as the
most intense, which indicates more labeled PS accumulation inside the cell lines with
time (Figure 3.6f).

The internalization of labeled PS NPs followed the “passive delivery” method. Here, a
non-specific cellular endocytosis results in NP sequestration within the endocytic vesicles
and leads to specific fluorescent points within the cytoplasm [42]. These fluorescent
points remain within the endosomes and lysosomes for several days. This “passive
delivery” method is one of the first mechanisms employed by cell lines. Major advantage
of passive delivery is that further modification of the NP surface is not required [42].
Therefore, the fluorescent labeled ginseng PS gave very intense images within tumor
induced murine macrophages cells with no significant background noise, which strongly
suggests their potential to examine the role of PS within tumor or cancer cells.
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Figure 3.6. Confocal laser scanning microscopy images of macrophage cell lines after
incubation with 200 µg/mL FTSC labeled ginseng polysaccharides nanoparticles after (a)
0, (b) 2, (c) 4, (d) 6, (e) 24, (f) 48 h. The cells were washed with PBS prior to confocal
analysis.

As part of the innate immune response, macrophages recognize and are activated by
pathogen-associated molecular patterns microorganisms. Consequently, there is a
significant change in transcriptional output in macrophage cell lines [43, 44]. Expression
profiling has revealed thousands of genes that are induced or repressed in macrophages in
response to the classical activating agent LPS. The response to LPS is initiated via a
signaling complex that includes CD14, toll-like receptor 4 (TLR4) and MD2 [43, 44].
Due to this transcriptional response to LPS in macrophages, we anticipated that there
might be alterations in the cellular uptake of labeled ginseng PS after activation with
LPS. To examine this, the macrophage cells were stimulated with LPS for 24 h prior to
the treatment with labeled ginseng PS NPs and then analyzed using confocal microscopy.
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Figure 3.7 shows the cell uptake images of labeled ginseng PS NPs by macrophage cell
lines (RAW264.7), indicating an increase fluorescent signal (Figure 3.7a), compared to
those cells without LPS treatment (Figure 3.7b). The results indicate that LPS activates
macrophages. The activated macrophages have increased levels of lysosomal proteins
and more passage in cellular basal layer that ultimately increases the more uptake of
labeled ginseng PS NPs [43, 44].

Figure 3.7. Confocal laser scanning microscopy images of macrophage cell lines (a)
pretreatment with LPS for 24 h and further incubation with FTSC labeled ginseng
polysaccharides nanoparticles (200 µg/mL), (b) treatment with FTSC labeled ginseng
polysaccharides nanoparticles (200 µg/mL). The cells were washed with PBS prior to
confocal analysis.

Another type of experiment was further performed to investigate the fate of cell lines
after adding water instead of PBS. To examine this, the macrophage cell lines were
treated with 200 µg/mL of labeled PS NPs and incubated for 24 h. Before investigation,
the cell lines were washed with PBS and then water was added while the cell lines were
investigated using confocal microscopy. From the resulting confocal images (Figure 3.8),
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it was observed that cell density gradually decreases with time. After 30 min of adding
water, no live cells were found. Usually PBS is used in cell biology experiments to
maintain the osmolarity of the cells as it contains salt ions, which balances the amount of
salt ions inside the cell. If the cells are immersed into a solution that has a strong salt
concentration, water will leak out from the cell, causing the cell to shrink. Conversely, if
the cells are immersed in a solution that has too few salt ions, water will enter the cell,
causing the cell to rupture [45]. In this experiment, water acts as hygroscopic solution for
the investigated cell lines which causes the cell to burst and ultimately die. Therefore,
PBS is at the correct osmolarity solution to keep the cells in an isotonic state.

Figure 3.8. Confocal laser scanning microscopy images of macrophage cell lines after
adding water instead of PBS. Cells were treated with 200 µg/mL FTSC labeled ginseng
polysaccharides NPs for 24 h, then washed and added water as hygroscopic solution.
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Activated macrophages have a profound effect on the direct killing of infected or
oncologically transformed cells by producing effectors molecules (cytokines and reactive
oxygen and nitrogen containing compounds) which help to eliminate abnormal tumor
cells [46, 47]. In this study, PS NPs from NA ginseng were shown to stimulate tumor
induced murine macrophage cell lines, in agreement with the mechanism reported by
many others [47]. Moreover, labeling of ginseng PS NPs provides additional rationale to
use as fluorescent tags for imaging target molecules transported in living cells by
fluorescent microscopy. Although FTSC labeled ginseng PS NPs appears to be efficiently
uptaken by macrophage cell lines, future work will be needed to further determine the
quantification and detailed nature of interaction between these NPs and cell lines.

3.4 Conclusions
In this work we have developed a facile and an efficient procedure for the fluorescent
labeling of ginseng polysaccharide NPs by coupling with FTSC dye based on the
reductive amination method. The prepared labeled PS have a diameter of 20 nm with
excellent fluorescent intensity. We demonstrated cellular uptake as a function of time and
observed that after 4 h of treatment, the labeled PS was successfully uptaken by cell lines
and the materials were stable even after 48 h of treatment. In addition, PS-FTSC
derivative exhibited almost no cytotoxicity against tumor induced murine macrophage
cell lines. The labeled PS NPs was also found to cause a significant increase in
macrophage production of cytokines TNF-α, IL-1β, Il-6 and in the production of
antimicrobial product NO. Therefore, the developed approach provides a convenient and
highly efficient fluorescent labeling procedure for understanding the mechanism of
ginseng PS uptake that can be considered as a potential therapeutic agent against tumor or
cancer cell proliferation.
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Chapter 4

Encapsulation of ginseng polysaccharides within
gelatin nanocarriers for efficacious oral delivery
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Abstract
Polysaccharides are an emerging class of active pharmaceutical ingredients (APIs) from
ginseng, which have been recognized to have unique pharmaceutical effects, although
how to control their degradation and delivery is poorly understood. In the present study,
polysaccharide nanoparticles (PS-NPs) which we have previously shown to have potent
immunostimulating

activity,

were

encapsulated

within

biodegradable

gelatin

nanospheres. An in situ two-step desolvation method was employed to encapsulate
ginseng PS NPs within gelatin nanospheres. The encapsulated ginseng PS NPs were
characterized by various physico-chemical techniques including SEM, TEM, FTIR, DLS,
BET and XRD. The experimental data showed that the gelatin nanospheres were uniform
with average diameters of 180 nm (±10 nm) and a mesoporous structure with average
pore size of 3.84 nm. To confirm the encapsulation of PS in gelatin NPs, fluorescentlabeled PS was encapsulated in gelatin NPs, which were identified by confocal laser
scanning microscopy (CLSM). The release kinetics of PS from gelatin NPs in phosphate
buffer saline (PBS) was studied using UV-Vis spectrometry, monitoring the release
profile for 7 days. The release rate of PS from the gelatin NPs decreases with increasing
the concentration of the cross-linker while the release profile follows a diffusioncontrolled release mechanism. Our results also indicate that acidic conditions help delay
the release profile of PS from gelatin NPs. The encapsulated PS NPs exhibited almost no
cytotoxicity effect against tumor induced macrophage cell lines (RAW 264.7) while
retaining high immunostimulating activity similar to the non-encapsulated ginseng PS
NPs. This approach can be utilized for the integration into capsules for subsequent oral
drug delivery.
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4.1 Introduction
Ginseng is a perennial plant discovered more than 5,000 years ago and is currently one of
the best-selling medicinal plants in the world [1]. The two most commonly recognized
species of ginseng are Asian ginseng (Panax ginseng) and North American ginseng
(Panax quinquefolium). North American ginseng is native to both Canada and the Eastern
United States and has been recognized as a valuable ‘tonic’ similar to Asian ginseng [14]. Polysaccharides (PS) derived from ginseng (Panax quinquefolium) root, have been
shown to provide immunomodulation, anti-tumor, anti-adhesive, antioxidant and
hypoglycemic activities [3-8]. In particular, COLD-FX®, a commercially available
natural health product isolated from North American ginseng root, contains 80% polyfuranosyl-pyranosyl-saccharides, and has been clinically used for the prevention of upper
respiratory tract infections [4, 9]. However, controlled release formulations are not
readily available.
The oral route is the most convenient way to administer drugs and bioactive compounds
(e.g. ginseng PS) [10]. In order to obtain the pharmacological effects, the bioactive
materials need to be absorbed across the intestinal barrier into systematic circulation. But
intestinal absorption of bioactive compounds is limited because of their physicochemical
properties including molecular size, biological half-life, solubility, and conformational
stability. Moreover, poor bioavailability of bioactive compounds also occurs due to the
degradation of them by gastrointestinal tract enzymes and poor permeability of the
intestinal mucosa [11-13]. Orally administered ginsenosides have been reported to
demonstrate low bioavailability due to their low membrane permeability across the
intestinal mucosa, active biliary excretion, decomposition in the stomach, metabolism in
the large intestine and elimination in the liver. Of these factors, low membrane
permeability and active biliary excretion have been attributed as the two major factors
that limit the absorption of orally administered ginsenosides from the gastrointestinal
tract into systemic circulation [14-17]. PS of medicinal plants such as Radix
ophiopogonis (Mw = 4.8 kDa) have been reported to have low bioavailability of about
1.7 % in rats after oral administration, which was attributed to their large molecular size
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and hydrophilic characteristics [18]. Hence, delivery of polysaccharides is a current
challenge, particularly in the oral cavity where pH sensitivity is required.
Gelatin is a pH sensitive hydrogel that is obtained either by partial acid or alkaline
hydrolysis of animal collagen [19]. Having a long history of safe use in pharmaceuticals,
cosmetics, as well as food products, it is considered as generally regarded as safe (GRAS)
material by the United States Food and Drug Administration (FDA) [20, 21]. It is used
clinically as a plasma expander and included as a stabilizer in a number of protein
formulations, and vaccines [20]. Gelatin offers the advantages of being cheap and readily
available. It has attracted a great interest for its biocompatibility, biodegradability and
relatively low antigenicity. Moreover, gelatin does not produce harmful by-products upon
enzymatic degradation, as it is derived from collagen, which is the most abundant protein
in animals. Gelatin chains contain motifs such as Arg-Gly-Asp (RGD) sequences that
modulate cell adhesion, thereby improving the final biological behavior over polymers
that lack these cell-recognition sites [22]. Gelatin nanoparticles (NPs) have added
advantage of possessing free amino groups on their surface which can be used for
attaching target molecules to the surface [23, 24].
In order to synthesize these gelatin NPs, several techniques have been including the
desolvation technique [25, 26], coacervation [27] and water-in-oil (w/o) emulsion [28,
29]. In the case of w/o emulsion technique, a large amount of surfactant is normally
required to produce the small-sized NPs, which requires subsequent post-processing [30].
The coacervation method is a process of phase separation followed by a cross-linking
step. However, non-homogeneous cross-linking can occur using this method as most
cross-linking occurs on the surface compare to interior of the particles [31].
Till now, there is no viable method to encapsulate PS NPs for controlled delivery in a pH
sensitive environment such as the oral cavity. This work reports on a new in situ route to
encapsulate ginseng PS within gelatin NPs while subsequently examining the cytotoxicity
and immunostimulating properties. A desolvation method was developed in order to
overcome the aforementioned problems to produce uniformly glutaraldehyde cross-linked
gelatin NPs. The nanoencapsulation products, i.e. ginseng PS loaded gelatin NPs were
characterized in terms of morphology, particle size, water content, PS release, cross96

linking degree and pH sensitivity. Furthermore, using murine macrophage cell lines
(RAW 264.7) the cytotoxicity and immunostimulating properties were examined.

4.2 Experimental
4.2.1 Materials
Polysaccharide was isolated and fractionated from North American ginseng root as
previously described [32]. Gelatin from porcine skin (Type A), glutaraldehyde solution
(25% in H2O), 0.1 mol/L phosphate buffered solution (PBS, pH 7.4), acetone was
purchased from Sigma-Aldrich, Canada and used as received. Purified water was
produced from a Milli-Q water purification system (18.2 M+·cm resistivity, Barnstead
EasyPureII, Thermo Scientific, USA). RAW 264.7 (ATCC TIB 67) murine macrophage
cell lines were provided by Dr. Jeff Dixon (Department of Physiology and Pharmacology,
Western University, Canada). BD OptEIA ELISA kits (for tumour necrosis factor-α,
Interleukin-1β, Interleukin-6) were purchased from BD Biosciences (Bedford, MA,
USA). LPS (Lipopolysaccharides) from Escherichia coli (0111:B4) and Griess reagent
were purchased from Sigma-Aldrich (USA). Cell culture medium and reagents were
purchased from Gibco laboratories (USA).

4.2.2 Nanosizing and labeling of ginseng PS
A T-junction microfluidics system was used based on our recently reported
nanoprecipitation mechanism for the synthesis of ginseng PS NPs [32]. The system
contains two infusion syringe pumps; one used for aqueous solution of PS and the second
one was used for pumping acetone, used as an anti-solvent. Here, we used the flowrate of
aqueous solution of ginseng PS 0.01 mL/min and anti-solvent flowrate 0.2 mL/min. The
formed NPs were then directed into a 5 mL reservoir solution containing acetone, placed
directly underneath the Micro-TEE at room temperature. Finally, the formed NPs were
collected by centrifugation at 4500 rpm for 10 min and dried by using freeze dryer
overnight.
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Sodium borohydride cyanide was added in a mixture of dimethyl sulfoxide and glacial
acetic acid with the ratio of 7:3. The reactant mixture was stirred for 30 min at room
temperature. Ginseng PS NPs and FTSC dye was added to the sodium borohydride
cyanide solution. The mixture was stirred for 4 h at 5400 rpm at room temperature. Then
the reaction was continued at 75oC for 8 h. The yellow colored product was collected by
centrifugation at 4000 rpm for 10 min and washed with deionized distilled water to
remove any free dye. The final yellow product was lyophilized using a freeze dryer at 50oC under reduced pressure to produce labelled PS NPs as powdered form.

4.2.3 Synthesis of gelatin NPs
Gelatin nanoparticles (NPs) were fabricated using a modified two-step desolvation
method [26, 33]. At first, 75 mL of 5 % (w/v) type A gelatin (300 bloom) solution was
precipitated with 75 mL acetone at 45°C for 45 min. The precipitate was separated and
used in the second desolvation. For this step, the high molecular weight (HMW) was redissolved in 20 mL acidic solution (pH=2.5) at 45°C with continuous stirring. The
isoelectric point of gelatin is 6 and in order to form its nanoparticles, the pH has to be
adjusted away from its isoelectric point. At this pH (2.5), the formed nanoparticles were
positively charged. So, the electrostatic repulsion prevented the polymer chains from
undesired aggregation. After stirring 10 min, ginseng PS (0.125 g) was added to the
gelatin solution. In the next step, 75 mL of acetone was added drop wise to the gelatin
solution. Then the cross-linker, 25% glutaraldehyde (four different ratios 0.01%, 0.02%,
0.035%, 0.05% were used) was added
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Scheme 4.1. Schematic illustration of polysaccharide-loaded gelatin NPs produced by
two-step desolvation process. (a) aqueous solution of gelatin; (b) first step desolvation;
(c) high molecular weight (HMW) and low molecular weight (LMW) gelatin separation
(d) aqueous solution of high molecular weight of gelatin; (e) PS loaded in aqueous
gelatin; (f) dropwise addition of acetone and formation of gelatin NPs and (g)
stabilization of gelatin NPs by glutaraldehyde (cross-linker).

to the reaction mixture to form the stable gelatin NPs. The solid gelatin particles were
separated from solution through centrifuging at 6000 rpm for 10 min at 4oC. The product
was washed by water/acetone (70/30) in a water bath at 45oC, and washed three to five
times. Finally, the NPs were lyophilized using a freeze dryer (Labconco) at -50oC under
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reduced pressure. The process is described schematically in scheme 4.1. Crosslinking is
an inevitable step in the preparation of gelatin NPs. Crosslinking step may also form
inter-particular crosslinks simultaneous to intra-particular crosslinks, which may lead to
aggregation [34] as illustrated in Scheme 4.2.

2
NH

NH

2
NH

A
GT

Scheme 4.2. Cross-linking reaction of gelatin with glutaraldehyde. Inside the box,
schematic representation of glutaraldehyde crosslinked gelatin nanoparticles, (i)
intraparticular crosslinks, (ii) interparticular crosslinks.

4.2.4 Material chararterization
The morphologies of the samples were examined using Scanning Electron Microscopy
(SEM) (Model LEO 1530). Samples for SEM imaging were prepared by applying the
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powder directly to a carbon adhesive tape and coating with a thin layer of osmium in a
vacuum chamber. The size distribution of the NPs was assessed by DLS using a Malvern
Zetasizer Nano ZS® instrument, (Nano S model ZEN 1600, Malver, Orsay, France) at
room temperature. FTIR spectra of ginseng PS loaded gelatin nanosphere were obtained
using a using a Thermo Scientific Smart iTR with Diamond ATR Crystal at room
temperature and OMNIC software at a resolution of 4 cm-1 and 128 scans. X-ray
diffraction (XRD) of the gelatin NPs crystallinity was obtained with a Bruker D2 Phaser
bench-top X-ray powder diffractometer using Cu Kα radiation (λ for Kα=1.54059 Å) at
30 kV and 10 mA. Dry powder samples were used with patterns collected in step-scan
mode with a small grazing angle of incident X-ray with a 2θ scan range of 10 to 80 and a
step size of 0.25. The Brunauer–Emmett–Teller (BET) surface area and pore size were
determined from nitrogen adsorption and desorption isotherm data obtained at 77 K. BET
experiments were carried out with a constant volume adsorption apparatus (Micromeritics
TriStar II 3020) with N2 gas (99.995% pure; obtained from Praxair, Canada). The gelatin
NPs sample was degassed at 150°C overnight before measurements. To identify the
location of fluorescent labeled PS in gelatin NPs, the fluorescent labeled PS was
encapsulated in gelatin NPs, which was studied by using a Zeiss (LSM 510 Duo)
Confocal laser scanning microscopy (CLSM) with the excitation wavelength (λex) at 490
nm.

4.2.5 Releasing and swelling study
The releasing profiles of PS from gelatin NPs were monitored using a UV-Vis
spectrophotometer (Shimadzu UV-3600). The standard curve was plotted to represent the
correlation of the concentration of PS and the corresponding intensity in the absorbance
in UV-Vis spectra. Different ratios of glutaraldehyde (25%) were used during gelatin
synthesis experiment reaction to harden the gelatin NPs. On the other hand, PBS with pH
value at 1, 4.5, and 7.4 were applied, respectively, to study the releasing kinetics of the
PS encapsulated within gelatin NPs. All the experiments for each time interval were
measured triplicates. The effects of the amount of cross-linker, and the pH value on the
swelling behavior of the gelatin NPs were investigated to find out the mechanism of the
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releasing kinetics. The swelling ratios of the samples were calculated based on the
equation below;

=

× 100% ……………………………………………..(4.1)

where, Ws and Wd are the weights of swollen and dried spherical NPs, respectively.
Each experiment was carried out in triplicate.

4.2.6 Encapsulation efficiency
The PS content in the loaded particles was estimated by dispersing a known amount of
particles in 10mL of a pH 7.4 PBS and stirring vigorously for 24 h. The dispersion was
centrifuged and the PS content in the supernatant liquid was determined by measuring the
absorbance at 270 nm with UV-Vis spectrophotometer, and compare it to a standard
curve. The percentage of drug loading and percentage of encapsulation efficiency were
calculated using the following equations. The experiments were performed in triplicate.
=

× 100%..........................(4.2)

=

× 100%...........................................................(4.3)
=

× 100%....(4.4)

4.2.7 Immuno-stimulatory assays
Macrophage cell line (RAW264.7) was cultured in Dulbeccos Modified Eagle’s Medium
supplemented with 10% Fetal Bovine Serum, 25mM Glutamine, 100 IU/ml penicillin and
100 µg/ml streptomycin. Cells were seeded in 96-well tissue culture plates at a density of
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1.5x105 cells per well and maintained at 37oC in a humidified incubator with 5% CO2. To
evaluate the dose-related stimulation of inflammatory mediators, an in vitro study was
carried out by treating and incubating macrophages with 0, 25, 50 and 200 μg/mL of
encapsulated and non-encapsulated ginseng PS NPs or 1 μg/mL of LPS (positive control)
for 24 h. Then, quantification of inflammatory mediators, nitric oxide (NO), tumour
necrosis factor-α (TNF-α) and interleukin-6 (IL-6) was carried out to investigate the
immunostimulating effect of ginseng PS.

Nitric oxide production was analyzed by the accumulation of nitric oxide in a cell culture
medium. Nitric oxide in culture supernatants was determined with Griess reagent (SigmaAldrich, USA). Briefly, 50 µL of culture supernatant from each sample was transferred to
wells of a 96-well U-bottom microtiter plate, 50 µL of Griess reagent (containing 0.5%
sulfanilic acid, 0.002% N-1-naphtyl-ethylenediamine dihydrochloride and 14% glacial
acetic acid) was then added. The absorbance at 550 nm wavelength was measured using
Multiscan Spectrum microplate reader (Thermo Fisher Scientific, Finland). Nitric oxide
concentrations in samples were estimated from standard curve prepared using sodium
nitrite.

IL-1β, IL-6 and TNF-α pro-inflammatory mediators were measured in culture
supernatants with a solid phase enzyme-linked immunosorbant assay (ELISA) (BD
OptEIATM) employing the multiple antibody sandwich principle [35]. Culture
supernatants were added to each well of 96-well microtiter plates, precoated with
polyclonal antibody specific for the investigated mediators IL-1β,6, and TNF-α, then
incubated for 2h at room temperature. After washing away (5 times) unbounded
substances, the culture was incubated for an additional 2h with polyclonal anti-murine
IL-1β, IL-6 and TNF antibody conjugated to horseradish peroxidase. After washing (7
times) to remove any unbound antibody-enzyme reagent, tetramethyl benzidine was
added as a peroxidase substrate and the reaction was stopped after 30 min. Absorbance
was collected at 450 nm using an automated Spectra Count microplate reader (Packard
Instrument Co., Meridan CT).
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Cell viability was performed using the 3-(4,5-dimethythiazol-2-yl)-2,5-diphenyl
tetrazolium bromide (MTT) assay, to determine in vitro toxicity of the gelatin particle.
This is a colorimetric assay based on reduction of MTT by mitochondrial succinate
dehydrogenase in metabolically active cells. The MTT is converted to a dark purple
colored formazan product, which is solubilised with DMSO and quantified
spectrophotometrically as a measure for viability of the cells, since reduction of MTT can
only occur in metabolically active cells.

Macrophage cell lines (RAW264.7) was used for cytotoxicity studies. Cells were cultured
at a density of 1x104 cells per wall in a 96-well plate for 24h. 100μL of NPs diluted with
cell culture media were put in each well and incubated at 37ºC for 24 h. After the
exposure time, the culture medium was removed from the 96-well plate and 150 μL MTT
solution (0.5 mg/mL) was added to each well and incubated for another 4 h. Then, the
medium was carefully removed from the plate, and 100 μL DMSO was added in each
well to solubilise the formazan produced from MTT by the viable cells. The amount of
viable cells in each well was determined by the absorbance of solubilised formazan.
Absorbance was measured at 540 nm using a microplate reader.
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4.3 Results and discussions
4.3.1 Morphology and size distribution of gelatin encapsulated
ginseng PS NPs
As described in chapter 3, ginseng PS was extracted from NA ginseng root, ginseng PS
NPs were synthesized using microfluidic device and then labeling of ginseng PS NPs was
carried out using FTSC, a fluorescent dye for the present study. SEM and TEM were
used to confirm the particle size and shape of ginseng PS NPs prepared by microfluidic
device. From these images (Figure 4.1a,b), it is clearly observed that the NPs were
formed with uniform spheres and smooth surfaces. The particle size was in the range of
15-30 nm (Figure 4.1b), with an average size of 20 nm. This small sized and narrow size
distributed NPs are most desirable for the controlled drug delivery system [36]. The
morphology of gelatin NPs after ginseng PS NPs loading was analyzed using SEM and
TEM as shown in Figure 4.1 c,d. Gelatin formed spherical NPs

with no surface

heterogeneity. The morphology of bare gelatin without loading ginseng PS was also
studied and did not found any significant differences in morphology.

The size

distribution was estimated from the TEM images by using ‘ImageJ’ software and also by
using DLS nanosizer instrument. In both cases, a sharp distribution was found with an
average size 180 nm (Figure 4.1 e,f). Figure 4.1 (g) represents the proposed drug delivery
system. The outer sphere is gelatin that acts as nanocarrier which makes crosslinked
network inside the sphere and entraps ginseng PS within their structure.
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Figure 4.1. (a) SEM image, and (b) TEM image of ginseng polysaccharides NPs; (c)
SEM image and (d) TEM image of ginseng polysaccharides loaded gelatin nanospheres;
(e) size distribution using DLS, (d) size distribution (of image 4.1d) measured by ‘ImageJ
software’ and (f) schematic of proposed drug delivery system.
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To study the effect of the concentration of glutaraldehyde as a cross-linking agent,
different amounts of glutaraldehyde was added to the gelatin NPs. Figure 4.2 (a-d), show
the SEM micrographs of gelatin NPs with different ratios of glutaraldehyde with gelatin,
0.01%, 0.02%, 035%, 0.05% respectively. It is demonstrated that the morphology and
monodispersity of NPs is dependent on the amount of cross-linker. It was observed, with
the cross-linker ratio 0.01%, there was no stable gelatin NPs formed (Figure 4.2a). After
increasing the cross-linker ratio to 0.02%, the most isolated and homogeneous sized
gelatin NPs formed (Figure 4.2b). Further increase of the cross-linker concentration to
0.035% (Figure 4.3c), the formed NPs were aggregated compared to the particles
prepared with 0.02% (Figure 4.2b). At glutaraldehyde concentration 0.05%, the prepared
gelatin NPs were clustered together (Figure 4.3d). The aggregation of gelatin NPs (with
the glutaraldehyde concentration of 0.035% and 0.05%) was happened due to the
formation of interparticular aggregation as shown in Scheme 4.2. Thus it can be said that
the cross-linker concentration of 0.02% is necessary to produce the stable gelatin NPs
with the average size of 180±10 nm.

4.3.2 Structural characteristics of gelatin encapsulated ginseng PS
Figure 4.3 (a) represents the FTIR spectra of PS, gelatin NPs and PS loaded gelatin NPs
respectively. FTIR spectrum of PS showed typical absorption bands at 3400-3500 cm-1
due to the characteristic bands of -OH, peaks at ~1030 cm-1 (for -O- group) is due to the
C-O-C stretching vibrations that are typical of ginseng-saccharide structures and at ~1700
cm-1 are assigned to the C=O functional group. The FTIR spectrum of gelatin shows the
characteristic peaks of C=O at ~1700 cm-1, peaks due to amine and hydroxyl group are
overlapped at 3400-3500 cm-1 and the peak at ~1500 cm-1 is assigned to the imine group
(-C=N-) formed through the cross-linking reaction of gelatin and glutaraldehyde.
Furthermore, the FTIR spectrum of PS loaded gelatin showed the characteristic peaks of
saccharide at ~1030 cm-1 (for ether group) and for gelatin at ~1500 cm-1 assigned for the
imine group that is formed due to the cross-linking reaction of gelatin and glutaraldehyde.
Therefore, all of these spectra confirmed the presence of PS within gelatin nanosphere.
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Figure 4.2. SEM image of gelatin nanoparticles with different concentration of crosslinker (glutaraldehyde) (a) 0.01%, (b) 0.02%, (c) 0.035%, (d) 0.05%.

X-ray diffraction studies are useful for investigating the crystallinity of the ginseng PS
encapsulated within cross-linked gelatin nanospheres. The XRD spectra for placebo
gelatin NPs (i), ginseng PS (ii) and ginseng PS loaded gelatin nanospheres (iii) are
presented in Figure 4.3 (b). The XRD pattern of PS NPs shows two peaks at 2θ of 13 and
20 degree region that is consistent with literature [37]. In case of gelatin NPs, it gives a
peak at 18 degree which also matches with the reported literature [28]. However, PS
loaded gelatin shows a more intense peak compare to the PS (without encapsulation) at
2θ of 20 degrees that is attributed to the encapsulation of PS within gelatin matrix.
Moreover, all the XRD peaks are broad, which indicates ginseng PS, gelatin and PS
loaded gelatin matrix have amorphous structure.
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Figure 4.3. (a) FTIR spectra and (b) XRD pattern of (i) gelatin nanospheres, (ii) ginseng
polysaccharides nanoparticles, and (iii) ginseng polysaccharides loaded gelatin
nanospheres.

4.3.3 Encapsulation performances
Drug loading and encapsulation efficiency values for each nanoparticle formulation are
presented in Table 4.1. As the amount of cross-linking agent, glutaraldehyde, increased
from 0.02 to 0.05%, the percent loading decreased, which in turn decreased the
encapsulation efficiency of the nanoparticles from 74% to 60.6%. It is apparent that as
the cross-linking amount increased, intra-particular and inter-particular crosslinking
increased (Scheme 4.2). Therefore, the available free volume for encapsulation or
entrapment of the ginseng PS molecules decreased, resulting in a reduction in the
encapsulation efficiency of PS in the nanoparticle matrix.
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Table 4.1. Drug loading and encapsulation efficiency of ginseng polysaccharides
nanoparticles loaded gelatin nanospheres.

Cross-linker amount

Loading efficiency

Encapsulation efficiency

(%)

(%)

(%)

0.02

51.3

73.9

0.035

45.7

66.1

0.05

42.1

60.6

The swelling behavior of gelatin NPs with different amounts of cross-linker were studied.
Figure 4.4 (a) represents the swelling curves of gelatin NPs in PBS (pH 7.4) as a function
of time (t) to different amounts of cross-linker. It reveals that swelling substantially
increases when t increases to 200 min, after that, the swelling approaches to saturation.
Figure 4.4 also indicates that when the cross-linker ratio of the polymer increased, the
swelling ratio of the hydrogel decreased. The reason is that with higher amount of crosslinker, the hydrogel matrix becomes harden and it increases the resistance for the
penetration of the medium through the hydrogel matrix. The percentage of swelling ratio
were further studied at pH 1.0, 4.5 and 7.4 for the gelatin NPs prepared with 0.02%
glutaraldehyde (Figure 4.4b). The prepared nano-system showed different water affinity
at different pH due to pendant acidic groups in the polymeric chains. In particular, at pH
1.0, there is a considerable lowering of the water affinity due to the acidic groups
unionized at this pH value. When the pH is increased up to 7.4, the water content is
greater than that found at pH 1.0. The fact is that at pH 7.4, the ionized forms prevail
which consequently results in an increasing swelling.

The effect of cross-linking on the in vitro release of PS from the gelatin NPs is shown in
Figure 4.4 (c). The releasing was continuously monitored for 6 days. The result indicates
that over 80% of PS was released during the first 80 h. The initial ‘burst effect’ is
110

observed in the first couple of hours due to a very quick release of drug physically
absorbed on the surface or within the upper layers of the nanoparticles, a typical effect of
diffusion–controlled polymer drug systems. For sustained release applications, the initial
release may help to reach a therapeutic regime, while the sustained release could help to
maintain the plasma concentration level [28].

From 20 h to 80 h, the encapsulated PS continuously released in a mild way, after 80 h,
the releasing is quite slow, and gets to saturation when releasing time (t) approaches to
120 h. During the releasing, the gelatin NPs might uptake water and swell, resulting in
the diffusion of PS molecules out from the nano-system. Meanwhile, the interaction
between PS (IP <5) and gelatin (IP>7) may delay the releasing.

Figure 4.4 (c) also reveals that increasing the glutaraldehyde amount decreased the rate of
release of PS from gelatin NPs. Poorly cross-linked NPs showed high PS release as a
result of poor diffusional limitations on drug transport. The diffusional limitations
become significant increasing the amount of cross-linking agent in the polymeric
nanostructure. The differences in the rate of PS release can be explained by the fact that
cross-linking typically hardens the gelatin matrix and also provides increased resistant for
the penetration of release medium into the system. Therefore, increasing the amount of
cross-linker, lowered the diffusivity of PS through the gelatin matrix.

All the releasing studies show that the gelatin NPs are able to encapsulate ginseng PS.
The mechanism of slow release may involve the following aspects: (1) water permeation
through the hydrogel matrix and absorption by the gelatin NPs, (2) gelatin NPs swelling,
(3) diffusion of PS molecules out through the swollen gelatin NPs.
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Figure 4.4. (a) Swelling behavior of gelatin nanospheres with different cross-linker
(glutaraldehyde) ratios (0.02%, 0.035%, 0.05%), (b) swelling behavior of gelatin NPs
(with cross-linker 0.02%) with different pH values (pH 1, 4.5, 7.4), (c) releasing profile
of gelatin nanospheres with different cross-linker (glutaraldehyde) ratios (0.02%,
0.035%, 0.05%), (d) releasing profile of gelatin NPs (with cross-linker 0.02%) with
different pH values (pH 1, 4.5, 7.4).

As gelatin (Ip >7) is a pH sensitive hydrogel, the releasing profile of PS from gelatin NPs
with different pH values were further studied and plotted in Figure 4.4(d). It represents
that PS released mostly at pH 7.4 and then 4.5 and 1.0 respectively. This is due to the
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presence of acidic pendant group, gelatin is undissociated at lower pH and that’s why low
amounts are released. When pH is 7.4, the swelling of the network increases and the
ionized form prevails; both these factors cause a significant increase in the amount of
released PS.

The properties of nanostructure and drug release are greatly influenced by the degree of
hydrogel crosslinking. Table 4.2 represents the surface area, pore volume and pore
structure of three different types of gelatin matrix (prepared with different amount crosslinker) measured by BET. The results reveal that NPs prepared with 0.02%
glutaraldehyde showed highest surface area, pore volume and pore size. The surface area
of the gelatin nanostructure decreased with increasing concentration of cross-linker. In
addition, the highest pore volume and pore size also observed with the NPs prepared with
0.02% glutaraldehyde, the lowest amount necessary for the stable gelatin NPs
preparation. Porosity decreased upon increasing the content of glutaraldehyde (crosslinker) because the cross-linker increased the molecular entanglement inside the gelatin
matrix, thereby decreasing the pore size and pore volume. Consequently, the NPs with
higher cross-linker density (0.035% and 0.05%) showed poor swell-ability and also lower
releasing rate compare to the NPs prepared with 0.02% cross-linker (Figure 4.4a,c).

Therefore, from all the experiments and investigations, it is observed that the optimum
weight ratio of cross-linking agent to gelatin is 0.02%. So, the gelatin NPs prepared from
this ratio was used for the remaining experiments.
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Table 4.2. Surface area, pore volume and pore size of different cross-linked gelatin
nanospheres.

Cross-linker amount

Surface area

Pore volume

Pore size

(%)

(m2/g)

(cm3/g)

(nm)

0.02

213

0.53

3.84

0.035

184

0.38

2.72

0.05

161

0.25

1.98

4.3.4 Cell viability and cytokines assay

MTT assay was used to assess the cytotoxicity of gelatin NPs. Six different
concentrations of non-encapsulated ginseng PS and encapsulated ginseng PS within
gelatin nanospheres were used to investigate the cell viability. In case of ginseng PS NPs
(without encapsulation), no difference in cell viability was observed compared to the
control over the examined concentration range (Figure 4.5a). On the other hand, MTT
assay indicates that encapsulated ginseng PS did not affect the cell viability at
concentration 500 µg/mL or lower (Figure 4.6b). At very high concentration (2000
µg/mL), less than 6% cells were damaged compare to the control group. The results show
no substantial cytotoxicity of RAW264.7 cells incubated with gelatin NPs for 24 h
(Figure 4.5b).

114

Figure 4.5. MTT assay of (a) Non-capsulated ginseng polysaccharides nanoparticles and
(b) Encapsulated ginseng polysaccharides nanoparticles within gelatin nanospheres to
evaluate the cell viability.

To identify the encapsulation of ginseng PS within gelatin NPs, dye (FTSC) labeled PS
was loaded within the gelatin using the same synthesis process described earlier [section
4.2.3]. A ZEISS LSM 5 Duo confocal microscope was used to take the fluorescence
images of the labeled ginseng PS loaded gelatin NPs using an argon laser at 488 nm and
magnification 20x. Figure 4.6 (a-c) represents the confocal images with different contrast
mode; bright field, dark field and the merge of bright and dark field. In the case of bright
field image (Figure 4.6a), the small spots represent the gelatin NPs. From this image, it is
not possible to locate the exact position of PS within the gelatin matrix. Figure 4.6b
represents the dark field image. In this image, the green signal stems from the dye labeled
PS located in the gelatin NPs. The merge image (Figure 4.6c) reveals that most of the dye
labeled PS are loaded within the gelatin nanospheres. In addition, the dye labeled gelatin
NPs were suspended in the liquid well, there is no aggregation detected from the Figure
4.6(a-c).
Labeled ginseng PS loaded gelatin NPs were further used for cellular uptake study.
Hence, murine macrophage cell lines (RAW264.7) were treated with 200 µg/mL of the
labeled PS loaded gelatin NPs and incubated for 24 h. Cells were washed with PBS
before confocal analysis to remove all the gelatin NPs that are not uptaken by the
investigated cell lines. Figure 4.6 (d-f) shows the cellular uptake and distribution of the
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labeled NPs within the cells. Bright field image represents the cell lines (Figure 4.6d).
The dark filed image (Figure 4.6e) shows the fluorescent signal which indicates that the
labeled PS loaded gelatin NPs has been uptaken by the cell lines. The overlay image
(merge of bright and dark field) illustrates that all the cell lines uptake the encapsulatedlabeled PS. This internalization of labeled PS NPs followed the “passive delivery”
method [38]. Here, a non-specific cellular endocytosis results in NP sequestration within
the endocytic vesicles and leads to specific fluorescent points within the cytoplasm.

Figure 4.6. Confocal laser scanning microscopy images of labeled ginseng
polysaccharides loaded gelatin nanoparticles (a) bright field image, (b) dark field image
and (c) merge image. Confocal laser scanning microscopy images of macrophage cell
lines. Cells were treated with 200 µg/mL dye labeled ginseng polysaccharides loaded
gelatin nanospheres for 24 h. The cells were washed with PBS prior to confocal analysis
(d) bright field image, (e) dark field image and (f) merge image.
Ginseng PS is known to have immune-stimulatory effects on macrophage cell lines [32,
39, 40]. So, it is important to examine the changes of this property after encapsulation of
ginseng PS. Macrophage cell lines RAW264.7 were used to investigate the
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immunostimulatory property of encapsulated and non-encapsulated ginseng PS NPs by
measuring the production of proinflammatory mediators (e.g., NO, TNF-α, IL-1β, IL-6).
As shown in Figure 4.7, murine macrophages were treated with 25, 50, 100 and 200
µg/mL of encapsulated and non-encapsulated ginseng PS NPs. The culture supernatants
were used for the quantification of the production of proinflammatory mediators. LPS
(lipo-polysaccharides) was used as a positive control and the macrophage cell lines
without any treatment as the negative control. The results reveal that stimulation of
macrophages with encapsulated and non-encapsulated PS NPs for the production of
inflammatory mediators is significantly higher than the untreated control (Figure 4.7 a,b).
All the particles upregulated macrophage production for all investigated mediators in a
dose-dependent manner.

Upon treatment with encapsulated ginseng PS (Figure 4.7a), macrophages produced low
levels of nitric oxide and other cytokines compared to the non-encapsulated ginseng PS
NPs (Figure 4.7b). The lower cytokines production is attributed to the encapsulation of
ginseng PS within gelatin nanostructure and the experiment was continued only 24 h
which indicates the slow release of PS from nanocarriers. Further, the experiment was
carried out with the released PS from gelatin nanoparticulate system. Released PS (from
gelatin nanostructure) were able to produce all investigated mediators (NO, TNF-α, IL1β), similar to the non-encapsulated PS. There is no difference noted in the cytokines
concentration with the released ginseng PS (from gelatin matrix) compared to the nonencapsulated one. Therefore, the encapsulation procedure did not diminish the
‘stimulatory’ property of ginseng PS.
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Figure 4.7. Immunostimulatory effect of: (a) encapsulated ginseng polysaccharide within
gelatin nanospheres, (b) non-encapsulated ginseng polysaccharides nanoparticles, (c)
released ginseng PS from gelatin matrix, on macrophage cell lines. Murine macrophages
were treated with four different concentrations of the treatment (25, 50, 100, 200 μg/mL),
LPS (1 μg/mL) for 24 h and the culture supernatants were analyzed for the production of
inflammatory mediators, (i) NO, (ii) TNF-α, (iii) IL-1β, and (iv) IL-6.
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4.4 Conclusions
A biodegradable nanosystem, gelatin NPs, has been developed as an efficient carrier for
delivery of the ginseng PS. The average diameter of gelatin NPs is approximately 180
nm±10 nm. They showed excellent swellability. The encapsulated PS is homogeneously
located inside the gelatin NPs. The release profile of PS from the gelatin nanoparticulate
follows a diffusion-controlled release mechanism. The releasing profile was monitored
for 6 days. The degree of cross-linking and pH sensitivity of the nanosystems were
investigated. The experimental results revealed that increasing the cross-linker amount
decreased both the release rate of PS from gelatin NPs and the swelling ratio of the
hydrogel. The experimental result also revealed that the developed nanosystems are pH
sensitive. All the studies confirm that the gelatin NPs are able to encapsulate ginseng PS.
It is expected that this biodegradable polymer nanoparticle can be a potential carrier for
the prolonged drug delivery.
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Chapter 5

Investigation of immunostimulating effect of ginseng
polysaccharide nanoparticles in the Albino male mice
through oral administration
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Abstract
Polysaccharides (PS) are a major active component of North American ginseng root
(Panax quinquefolius) showing various biological activities including anti-carcinogenic,
anti-aging, immunostimulatory and antioxidant effects. Although in vitro and in vivo
biological activity of ginseng PS extract has been reported by several groups, no research
has explored in vivo efficiency of nanosized and encapsulated ginseng PS. For the first
time, we investigated the effect of oral administration of different formulation of ginseng
PS. The treatment groups (n = 5 per group) were as follows: control (vehicle only),
ginseng PS (bulk), ginseng PS (NPs), labeled ginseng PS NPs and encapsulated ginseng
PS NPs. The treatment group received 50 mg/kg of ginseng PS material dissolved in
water by oral gavage once daily for 3 or 6 consecutive days. Intra-cardiac blood samples
were collected, inflammatory cytokine (TNFα) and reactive oxygen compound (NO)
levels were measured. The results reveal that all ginseng materials increase the
upregulation of cytokine and NO production compared to the control mice. Additionally,
6 days treatment of ginseng PS materials gave two times higher NO production compared
to that of the 3 days treatment group. Therefore, oral administration of ginseng PS
appears to potentiate immune response in mice.

125

5.1 Introduction
Ginseng is a medicinal plant widely used for the treatment of various conditions. The
pharmacological effects of ginseng have been demonstrated in cancer, diabetes,
cardiovascular diseases and have been used for promoting immune function, central
nervous system function, relieving stress, and for its antioxidant activities [1-4]. Panax
ginseng (Korean or Asian), Panax quinquefolius (North American or NA) are the two
most well-known ginseng varieties around the world. Like Asian ginseng, NA ginseng is
reported to have a variety of pharmacological effects [5, 6]. The extracts of ginseng
contain numerous active ingredients, in which polysaccharides (PS) are one of the most
important bioactive compounds, have been shown to provide immune-modulating effects
[7-12]. In particular, COLD-FX®, a commercially available natural health product
isolated from NA ginseng root, contains poly-furanosyl-pyranosyl-saccharides. COLDFX® has been clinically used for the prevention of upper respiratory tract infections [3,
13]. However, controlled release formulations are not readily available.

Oral delivery is the most common method for drug administration [14]. However, poor
solubility, stability, and bioavailability of many drugs make achieving therapeutic levels
via the gastrointestinal (GI) tract challenging [15]. Drug delivery must overcome
numerous hurdles, including the acidic gastric environment and the continuous secretion
of mucus that protects the GI tract [16]. Nanomedicine and nanocarriers that can shield
drugs from degradation and deliver them to intended sites within the GI tract may enable
more efficient and sustained drug delivery [15-17].

Ginseng is an activator of cellular immunity. Oral administration of the aqueous extract
of ginseng for 5 to 6 days significantly increased the natural killer (NK) cell activity by
44 to 150% [18]. Ginsana (G115), PS portion of ginseng, produced an adjuvant effect in
human volunteers who were vaccinated against influenza. Ginsana (G115) also
significantly elevated the level of NK cell activation [19]. Long-term oral administration
of 50% ethanol extract of ginseng for 52 days decreased the serum level of γ-globulin by
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56% [20]. A recent study revealed that male BALB/c mice treated orally with ginseng
root extract for 5 consecutive days had reduced serum level of IgG, but elevated IgA
level. Production of IgG by spleen cells also significantly decreased, but IgA production
was increased. IL-2, IFN-γ (Th1-type cytokine) and IL-10 (Tr1-type cytokine) production
by concanavalin (Con) A-stimulated spleen cells was up-regulated in ginseng-treated
mice compared to the control group [21]. Therefore, the pharmacological effects of
ginseng extract are affected by the fraction of the extract, dosage, administration, and
duration of treatment [22].

Our previous studies in this thesis have shown that ginseng PS, PS NPs, labeled PS NPs
and encapsulated PS enhances the immunostimulating activity of macrophage cell lines.
In the present study, we hypothesized that orally administered NA ginseng PS stimulates
the immunostimulating property. To investigate this hypothesis, an animal model (Albino
male mice) was used for oral gavage and then quantified the production of reactive
oxygen containing compound nitric oxide and organic cytokine tumor necrosis factor
(TNF-α). Albino mouse was used as a model, as they are small, convenient to handle,
housed and maintained. They also adapt easily to new environment [23].

5.2 Materials and methods
5.2.1 Extraction of PS from NA ginseng
Ginseng PS used in this study was extracted from NA ginseng root as described in our
previous work [24, 25]. Briefly, one gram of dried ground ginseng root samples was
soaked in 4 mL of deionized distilled water at 40oC for 2 h. After the extraction, the
solution was filtered and then concentrated by rotary evaporator and finally lyophilized
using a freeze dryer. A solution of aqueous ginseng extract in distilled water (1 g/mL)
was prepared as previously mentioned and PS content was precipitated by the addition
ethanol. The PS fraction was collected by centrifugation, and then lyophilized to produce
the crude ginseng PS. The crude PS was further dissolved in water and partitioned with
Sevag reagent (1:4 n butanol:choloform, v/v, 100 mL each) to remove the protein.
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Finally, the extract was precipitated using ethanol and lyophilized to obtain dried ginseng
PS.

5.2.2 Synthesis of ginseng PS NPs
A T-junction microfluidics system was used based on nanoprecipitation mechanism for
the synthesis of ginseng PS NPs. The system contains two infusion syringe pumps; one
used for aqueous solution of PS and the second one was used for pumping acetone, used
as an anti-solvent. The flowrate of aqueous solution of ginseng PS 0.01 mL/min and antisolvent flowrate 0.2 mL/min was used. The formed NPs were then directed into a 5 mL
reservoir solution containing acetone, placed directly underneath the Micro-TEE at room
temperature. Finally, the formed nanoparticles were collected by centrifugation and dried
by using freeze dryer.

5.2.3 Labeling of PS with FTSC
Sodium borohydride cyanide was added in a mixture of dimethyl sulphoxide and glacial
acetic acid with the ratio of 7:3. Ginseng PS NPs and FTSC dye was added to the sodium
borohydride cyanide solution. The mixture was stirred for 4 h at 5400 rpm at room
temperature. Then the reaction was continued at 75oC for 8 h. The yellow colored product
was collected by centrifugation at 4000 rpm for 10 min and purified with deionized
distilled water. Finally, the labeled ginseng PS NPs was lyophilized using a freeze dryer
at -50oC under reduced pressure.

5.2.4 Encapsulation of PS within gelatin nanospheres
An in situ two-step desolvation method was employed to encapsulate PS within gelatin
nanospheres as described in chapter 4. Briefly, 5 % (w/v) gelatin solution was
precipitated with acetone. The precipitate was separated and used in the second
desolvation. During this step, ginseng PS was added to the gelatin solution. Then the
cross-linker was added to the reaction mixture to form the stable gelatin NPs. The solid
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gelatin particles were separated from solution through centrifuging. Finally, the product
was washed and then lyophilized using a freeze dryer to obtain dried gelatin nanospheres.

5.2.5 Animals
Albino male mice (average weight 21g) were purchased from Charles River, St.
Constant, QC, Canada and housed in a temperature-humidity controlled facility operating
at a 12 h light and dark cycle. Animals were provided food and water ad libitum. Mice
were used in accordance with the guidelines of the Canadian Council on Animal Care.
The study protocols (Protocol No: 2009-070) were approved by the Animal Care
Committee at the University of Western Ontario, Canada.

5.2.6 Experimental protocols
Adult male mice were divided into six groups containing five mice each; i) ginseng PS
(bulk), ii) ginseng PS NPs, iii) labeled ginseng PS NPs, iv) encapsulated ginseng PS NPs,
v) sham control (vehicle). The treatment group received 50 mg/kg of ginseng PS
materials dissolved in water by oral gavage once daily for 3 or 6 consecutive days. The
sham control group received water orally. Mice were anesthetized with an intraperitoneal
injection of (100mg/kg) ketamine and (6mg/kg) xylazine solution. After being
anaesthetized, a cardiac puncture was performed to collect blood. Blood was centrifuged
(Beckman Model TJ-6, U.S.A) at 3000xg for 30min and supernatant was collected and
stored at -20˚C until use.
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Scheme 5.1. Schematic illustration of (step 1): extraction, nanosizing, labeling and
encapsulation of ginseng polysaccharides (step 2): Oral administration of ginseng
polysaccharides on Albino male mice. Four different treatment groups were used (a) bulk
ginseng polysaccharides, (b) ginseng polysaccharides NPs (c) labeled ginseng
polysaccharides NPs and (d) encapsulated ginseng polysaccharides NPs.

5.2.7 Nitric oxide assay
Nitric oxide production was analyzed by the accumulation of nitric oxide in blood serum.
Nitric oxide in blood serum was determined with Griess reagent (Sigma-Aldrich, USA).
Briefly, 50 µL of blood serum from each sample was transferred to wells of a 96-well Ubottom microtiter plate, 50µL of Griess reagent (containing 0.5% sulfanilic acid, 0.002%
N-1-naphtyl-ethylenediamine dihydrochloride and 14% glacial acetic acid) was then
added. The absorbance at 550 nm wavelength was measured using Multiscan Spectrum
microplate reader (Thermo Fisher Scientific, Finland). Nitric oxide concentrations in
samples were estimated from standard curve prepared using sodium nitrite.
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5.2.8 Quantification of tumour necrosis factor-α (TNF-α) assay
TNF-α was measured in blood serum with a solid phase enzyme-linked immunosorbant
assay (ELISA) (BD OptEIATM) employing the multiple antibody sandwich principle
[26]. The blood serum was added to each well of 96-well microtiter plates, precoated
with polyclonal antibody specific for TNF-α, then incubated for 2 h at room temperature.
After washing away (5 times) unbounded substances, the culture was incubated for an
additional 2 h with polyclonal anti-murine TNF antibody conjugated to horseradish
peroxidase. After washing (7 times), tetramethyl benzidine was added as a peroxidase
substrate. Finally, absorbance of the colored product was measured using an automated
Spectra Count microplate reader (Packard Instrument Co., Meridan CT).

5.3 Results and discussions
Our previous methodology was utilized for the extraction of ginseng PS from NA
ginseng root, nanosizing of ginseng PS using a microfluidic device [25], with subsequent
fluorescent labeling of ginseng PS and encapsulation of ginseng PS for the present study
(Chapter 3). This corresponds to step 1 in Scheme 5.1. TEM was used to confirm the
particle size and shape of ginseng PS NPs prepared by the microfluidic device. From the
TEM image (Figure 5.1a), it is clearly observed that the NPs were formed with uniform
spheres and smooth surfaces. The size distribution of the NPs is in the range of 15-30 nm,
with an average size of 20 nm. Monodispersed polymeric NPs can be effective in passing
through the mucus barrier as reported previously [27, 28]. Nanosized ginseng PS were
then labeled using fluorescein-5-thiosemicarbazide as dye for tracking the transport of
therapeutic agent PS NPs inside the cell. Confocal laser scanning microscopy (CLSM)
was used to characterize the FTSC dye labeled ginseng PS NPs. Figure 5.1b represents
the dark field image of labeled ginseng PS NPs, where the green signal emits from the
fluorescent dye within ginseng PS NPs. Further, ginseng PS was encapsulated within
gelatin nanocarriers using two-step desolvation method for the sustained release of PS.
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Figure 5.1c represents the SEM image of encapsulated ginseng PS NPs. From the
micrograph, it is observed the gelatin nanospheres are uniform with average diameter 180
nm (±10 nm).

Figure 5.1. (a) TEM image of ginseng polysaccharides nanoparticles prepared by
microfluidic system; (b) Confocal laser microscopic image of dye labeled ginseng
polysaccharides nanoparticles; and (c) SEM image of ginseng polysaccharides loaded
gelatin nanospheres.

Albino male mice were treated with 50 mg/kg of ginseng PS bulk, PS NPs, labeled PS
NPs and encapsulated PS NPs for 3 days through oral gavage. The blood serum was used
for quantification of the production of the reactive oxygen compound nitric oxide and
organic cytokine TNF-α. The results reveal that stimulation with ginseng PS for the
production of NO and TNF-α are significantly higher than the sham control (mice
without any treatment) as shown in Figure 5.2 a,b. Indeed, all types of ginseng PS
materials significantly up-regulated the production of NO and TNF-α. Our previous in
vitro results with ginseng PS NPs show a significant stimulating enhancement. Upon
treatment with bulk ginseng PS, macrophages produced low levels of nitric oxide and
other cytokines compared to the ginseng PS NPs [25]. In agreement of these result, here
we also observed that ginseng PS NPs produced increased amount of NO and TNF-α
compared to the bulk PS. On the other hand, labeled and non-labeled PS NPs produced
almost similar magnitude of NO and TNF-α production. The maximum NO and TNF-α
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production obtained using the encapsulated PS NPs (Figure 5.2. a,b), where
encapsulation enhances cytokines production. These results reveal that ginseng PS NPs
are more effective immunostimulating agents compared to the bulk ones and
encapsulated PS NPs even better than non-encapsulated one.

Figure 5.2. The effect of ginseng polysaccharides treatment on the production of NO and
TNF-α within blood sample of Albino male mice (n=5 mice per group). Mice were given
ginseng polysaccharides treatments or control (vehicle) for 3 consecutive days through
oral gavage and sacrificed. Different ginseng polysaccharide materials used: (i) PS1- bulk
PS, (ii) PS2- PS NPs, (iii) PS3- labeled PS, (iv) PS4- encapsulated PS. Blood serum was
used for NO and cytokines analysis. (a) NO production, (b) TNF-α production. Each
group had n =3, and the data is shown as mean ± SD.

Another experiment was performed to investigate the effect of NO and TNF-α production
with time. To examine this, Albino male mice were given ginseng PS NPs and
encapsulated PS NPs for 3 and 6 consecutive days. Oral treatment of Albino mice with
ginseng PS NPs and encapsulated PS NPs for 3 and 6 days treatment showed increased
production of NO and TNF-α which are higher than the sham control (Figure 5.3 a,b).
The 6 days treatment of PS NPs gave 2 times higher NO production compared to that of
the 3 days treatment. Similar response was also observed with the encapsulated ginseng
PS treatment, 6 days treatment of mice showed increased NO production than 3 days
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treatment. In addition, both the ginseng PS NPs and encapsulated PS for 6 days treatment
showed increased TNF-α production which is 15% and 25% higher than the 3 days
treatment. Therefore, it is concluded that immunostimulatory response of both ginseng
PS NPs and encapsulated PS NPs is time-dependent.

Figure 5.3. The effect of ginseng polysaccharides treatment on the production of NO and
cytokine within blood sample of Albino male mice (n=5 mice per group). Mice were
given ginseng polysaccharides treatments or control (vehicle) for 3 and 6 consecutive
days through oral gavage and sacrificed. Two different ginseng polysaccharide materials
used: (i) PS2- PS NPs and (ii) PS4- encapsulated PS. Blood serum was used for NO and
cytokine analysis. (a) NO production, (b) TNF-α production. Each group had a n =3, and
the data is shown as mean ± SD.

To determine whether the concentration of treatment has any impact on NO and
cytokines production, two different concentration of ginseng PS NPs and encapsulated PS
NPs were used for oral gavage. As shown in Figure 5.4, 50 mg/kg of ginseng PS NPs
treatment mice produced 22 µg/mL of NO and 47 pg/mL of TNF-α, while 75 mg/kg of
ginseng PS NPs treatment mice produced 32 µg/mL and 58 pg/mL respectively. Similar
observation was also noticed for encapsulated ginseng PS NPs. Hence, 75 mg/kg of
treated mice blood serum produced higher NO and TNF-α compared to 50 mg/kg of
treated mice blood serum. Therefore, the immunostimulatory effects of ginseng PS NPs
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and encapsulated PS NPs showed a dose-response relationship, exhibited by a marked
increased production of NO and TNF-α in effect at the high dosage treatment.

Figure 5.4. The effect of different concentration of ginseng polysaccharides treatment on
the production of NO and cytokine within blood sample of Albino male mice (n=5 mice
per group). Mice were given ginseng polysaccharides treatments or control (vehicle) for 3
days through oral gavage and sacrificed. Different ginseng polysaccharide materials used:
(i) PS2L- PS NPs with 50 mg/kg of treatment, (ii)

PS2L- PS NPs with 75 mg/kg of

treatment and (iii) PS4L- encapsulated PS with 50 mg/kg of treatment and (iv) PS4Hencapsulated PS with 75 mg/kg of treatment. Blood serum was used for NO and
cytokines analysis. (a) NO production, (b) TNF-α production. Each group had n =3, and
the data is shown as mean ± SD.

The oral route is the most convenient way to administer drugs and bioactive compounds
(e.g. ginseng PS). In order to obtain the pharmacological effects, the bioactive materials
need to be absorbed across the intestinal barrier into systematic circulation as shown in
Scheme 5.2a. But intestinal absorption of bioactive compounds is limited because of their
physicochemical properties including molecular size, biological half-life, solubility, and
conformational stability. Moreover, poor bioavailability of bioactive compounds also
occurs due to the degradation of them by gastrointestinal tract enzymes and poor
permeability of the intestinal mucosa [29-31].
135

Scheme 5.2. (a) Gastrointestinal absorption of orally administered biochemical
compounds into systemic circulation; (b) schematic depiction of the intestinal epithelium
and the pathways available for drug absorption (i) paracellular pathway (in between
adjacent cells) (ii) transcellular pathway (through the epithelial cells), (iii) absorption into
the lymphatic circulation via M-cells of Peyer’s patches; (c) schematic illustration of
swelling of hydrogel nanocarrier, biodegradtion and releasing of drug; (d) cellular
internalization.

Hence, by nanosizing ginseng PS extracts, they become more effective in bypassing the
GI barrier compare to the bulk one. The possible mechanism of ginseng PS NPs passing
through the GI tract include: (1) paracellular passage—particles “kneading” between
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intestinal epithelial cells due to their extremely small size (<50 nm); (2) endocytotic
uptake—particles absorbed by intestinal enterocytes through endocytosis (particles
size<500 nm); and (3) lymphatic uptake—particles adsorbed by M cells of the Peyer's
patches (particle size <5 μm) [scheme 2b] [16, 32, 33]. Moreover, encapsulation with
gelatin make ginseng PS NPs more bioavailable as the hydrogel nanocarrier can protect
the API (active pharmaceutical ingredients) from enzymatic degradation in acidic
environment in stomach and also provide sustained release of API. The mechanism of
slow release may involve the following aspects: (1) water permeation through the
hydrogel matrix and absorption by the gelatin NPs, (2) gelatin NPs swelling, (3) diffusion
of PS molecules out through the swollen gelatin NPs and finally biodegradation of the
carrier [Scheme 5.2c].

5.4 Conclusions
From this study it can be concluded that oral administration of ginseng PS significantly
upregulated the production of NO and TNF-α compared to the Sham control. The results
reveal that ginseng PS NPs are more effective immunostimulating agents compared to the
bulk one and encapsulated PS NPs even better than non-encapsulated one. This is
happened due to the GI permeability of ginseng PS which is related to the control rate
and extent of drug absorption and its bioavailability. Again, orally administered ginseng
PS NPs and encapsulated PS NPs significantly increased the production of NO and TNFα in a dose-dependant and time-dependant manner compared to the Sham control.
Therefore, orally administered ginseng PS can be considered as a therapeutic agent for
immunostimulation.
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Chapter 6

Photoprotective effect of ginseng polysaccharide
nanoparticles against UVB- induced skin damage in
the hairless mice
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Abstract
Ultraviolet (UV) radiation induced skin damage may result in cancerous skin lesions and
acceleration of skin aging due to an imbalance of the endogenous antioxidant system that
leads to an increase of free radical levels and inflammation. Therefore, antioxidant
supplementation might inhibit such an imbalance. In this regard, ginseng root is a
promising natural derived drug, which has proven anti-oxidative and anti-inflammatory
properties. Till now, there have been no studies reported on the photo protective effect of
North American (NA) ginseng polysaccharide (PS). Therefore, the purpose of this study
was to investigate the possible beneficial effects of topical formulations containing NA
ginseng PS nanoparticles (NPs) to inhibit UVB induced oxidative damage. Induction of
photoaging was conducted on SKH-1 hairless mice through UVB irradiation at 300mJ/cm2.
The treatment groups (n =5) were as follows: Control (BC), ginseng PS (bulk), ginseng PS
(NPs) and labelled ginseng PS NPs which were added into the base cream and applied on
the dorsal skin of mice. Two experiments were performed to assess ginseng PS protective
properties: one was pre-treatment and the other was post-treatment. Skin and blood were
collected, inflammatory cytokine (IL-1Β, IL-6, and TNFα) levels were measured using
ELISA, and the skin was analyzed through histology. The ginseng PS NPs treated blood
and skin sample showed a significant reduction in all cytokine production compare to the
control one. Additionally, histological analysis showed pre-treatment of ginseng PS NPs
prevented epidermal damage and proliferation. Therefore, the results suggest the possible
usefulness of topical formulations containing ginseng PS NPs to prevent UVB induced skin
damages.
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6.1 Introduction
Ultraviolet (UV) irradiation from the sunlight is the most important environmental factor
for dermatological disorders [1, 2]. In particular, UVB (280-315 nm) has been shown to
damage biological macromolecules, including lipids, proteins, and nucleic acids. UVB
plays a major role in the development of human skin cancer and has been shown to act as
a tumor initiator and tumor promoter in animals [3-6]. It is well established that the
inflammatory changes of the skin occur in response to acute exposure to UVB irradiation
[3, 7]. The overproduction of reactive oxygen species (ROS) formed under this condition
is presumed to play an important role in cutaneous diseases such as skin carcinogenesis,
skin aging and damage of epidermal cells [3, 8].

ROS act as secondary messengers in pro-inflammatory signaling cascades that induce the
production of cytokines [1]. These cytokines play an important role during inflammatory
processes. Two major cytokines, namely tumor necrosis factor-alpha (TNF-α) and
interleukin-1 beta (IL-1β) help to integrate the inflammatory response and initiate a cascade
of mediators. These mediators are directly responsible for the various events associated
with inflammation [1, 9]. IL-1β can also activate cell surface receptors on keratinocyte
cells that stimulates the production of other pro-inflammatory cytokines, including IL-8,
resulting in further epidermal inflammation. Additionally, the binding of IL-1β to its
receptor incites the stimulation of the activation protein 1 (AP-1) transcription factor,
triggering the transcription of matrix degrading enzymes such as matrix metalloproteinases
(MMPs), as well as genes that interrupt procollagen 1 synthesis. Together, the products of
the AP-1 transcription factor result in collagen degradation and imperfect repair within the
dermis leading to a loss of structural integrity within skin [10-12].

Clinically, photoaged skin is characterized by wrinkles, laxity, blister formation, and
impaired wound healing resulting from increased epidermal inflammation and matrix
degradation. Breakdown of the dermal matrix by MMPs, followed by imperfect repair,
results in the flawed structure and organization of the collagenous extracellular matrix,
known as solar scarring [13-15]. With each intermittent UV exposure, there is additional
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solar scarring undermining the structural integrity of the dermis, manifesting itself as
wrinkled skin. Histological changes, as a result of increased inflammation, result in hyper
proliferation of keratinocytes and disruption of the basement membrane of the epidermal
layer leading to thickening of the skin [12, 14-16]. Therefore, protection of the skin against
UVB induced photoaging requires enhancing the skin’s defense and recovery mechanisms,
which include the reduction of both inflammation and ROS.

Ginseng is one of the most widely used medicinal plants in traditional oriental medicine.
Panax ginseng (Asian ginseng) and Panax quinquefolium (North American ginseng) are
the most commonly recognized ginseng species. North American (NA) ginseng that is
grown in both Canada and Eastern U.S. has been recognized as a valuable tonic similar to
Asian ginseng [17, 18]. Polysaccharide (PS) is one of the major components of NA ginseng
extract that has been shown to have immunomodulatory effects [19, 20]. They have shown
to have possess anti-oxidative and anti-inflammatory properties and cancer prevention
effects [21-26]. Due to these properties, we hypothesized that NA ginseng PS may provide
a protective effect against photoaging, although there have been no studies verifying this
effect.

Recently, a study has shown that Korean ginseng was found to suppress expression of NFκB through the inhibition of phorbol 12,13-dibutyrate, thus indicating possible protection
against UVB induced photoaging [27]. In another study, it was reported that the topical
application of total ginseng saponins and ginsenoside Rb1 prevents UVB-induced skin
photoaging in hairless mice [28]. In addition, compound K, one of the major metabolites
of ginsenosides, induces the expression of hyaluronan synthase 2 genes and enhances
hyaluronan synthesis in HaCaT cells, increasing hyaluronan levels in the skin of aged
hairless mice [29]. Furthermore, red ginseng extract or compound K increases the levels of
type I procollagen and decreases the levels and activity of MMP-1 in UV-irradiated mice
or fibroblasts [30, 31]. These results have led us to hypothesize that NA ginseng PS could
inhibit UVB induced photoaging as there has been no report that stated this effect. In this
study, we investigate the biological and pharmacological effects of polysaccharides
isolated from the NA ginseng root on UVB induced skin damage in SKH1 hairless mice.
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6.2 Experimental
6.2.1 Extraction of PS from NA ginseng
Ginseng PS used in this study was extracted from NA ginseng root as described in our
previous work [32]. Briefly, one gram of dried ground ginseng root samples was soaked in
4 mL of deionized distilled water at 40oC for 2h. After extraction, the solution was filtered
at room temperature with the solvent removed by a rotary evaporator under vacuum at
45˚C. Filtered extracts were then lyophilized with a freeze dryer to produce aqueous
ginseng extracts in a powder form which contained 15% PS.
A solution of aqueous ginseng extract in distilled water (1 g/mL) was prepared as
previously mentioned and PS content was precipitated by the addition ethanol. The PS
fraction was collected by centrifugation, the precipitated was collected and then lyophilized
to produce the crude ginseng PS.
The crude PS was further dissolved in water and partitioned with Sevag reagent (1:4 nbutanol:choloform, v/v, 100 mL each) to remove the protein. Finally, the extract was
precipitated using ethanol and lyophilized to obtain dried ginseng PS.

6.2.2 Synthesis of ginseng PS NPs
A T-junction microfluidics system was used based on nanoprecipitation mechanism for the
synthesis of ginseng PS NPs [32]. The system contains two infusion syringe pumps; one
used for aqueous solution of PS and the second one was used for pumping acetone, used
as an anti-solvent. Here, we used the flowrate of aqueous solution of ginseng PS 0.01
mL/min and anti-solvent flowrate 0.2 mL/min. The formed NPs were then directed into a
5 mL reservoir solution containing acetone, placed directly underneath the Micro-TEE at
room temperature. Finally, the formed nanoparticles were collected by centrifugation at
4500 rpm for 10 min and dried by using freeze dryer for overnight
146

6.2.3 Labeling of PS with FTSC
Sodium borohydride cyanide was added in a mixture of dimethyl sulphoxide and glacial
acetic acid. The reactant mixture was stirred for 30 min at room temperature. Ginseng PS
NPs and FTSC dye was added to the sodium borohydride cyanide solution. The mixture
was stirred for 4 h at 5400 rpm at room temperature. Then the reaction was continued at
75oC for 8 h. The yellow colored product was collected by centrifugation at 4000 rpm for
10 min and washed with deionized distilled water to remove any free dye. The final yellow
product was lyophilized using a freeze dryer at -50 oC under reduced pressure to produce
labeled PS NPs as powdered form.

6.2.4 Animals
Female eight-week-old SKH-1 hairless mice were purchased from Charles River Canada
and housed in a temperature-humidity controlled facility operating at a 12 h light and dark
cycle. The mice were allowed to adapt to their surroundings for five days before beginning
experiments. The study protocols (Protocol No: 2009-070) were approved by the Animal
Care Committee at the University of Western Ontario, Canada.

6.2.5 UVB irradiation
The UV apparatus consisted of four UVB lamps in which the radiant dose was quantified
using a UV light detector. UVB light was irradiated from 40 cm above the dorsal surface
of the mice and the UVB dose used for experiments was a single exposure of 300 mJ/cm2.
The mice were placed in individual compartments in a closed plastic apparatus to ensure
even distribution of irradiation.
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6.2.6 Treatment
Ginseng PS, ginseng PS NPs and labeled ginseng PS NPs were dissolved in ethanol–
propylene glycol with the concentrations of 30 mg/mL of PS. Solutions were then added
into a base cream such that the final concentration of PS was 0.6 mg/g cream. The base
cream contained water and olive oil as major ingredients and silicone oil and jojoba oil as
minor ingredients. The cream was topically applied onto the dorsal region of the mice at a
dose of 6 mg/kg body weight of ginseng PS.
Mice were divided up equally into UVB irradiated and non UVB irradiated groups. Within
each group they were further divided up into four treatment groups containing five mice
each; 1) ginseng PS, 2) ginseng PS NPs, 3) labeled ginseng PS NPs and 4) control (Base
cream).

6.2.7 Assessing the protective effect of ginseng
Cream containing a specific treatment was applied to the backs of the mice for three
consecutive days. On the fourth day mice were either given UVB irradiation or a sham
treatment followed by sacrificing 24 h later (Scheme 6.1, step 2, pre-treatment).

6.2.8 Assessing the recovery effect of ginseng
Mice were either given UVB irradiation or a sham treatment followed by cream application
to their backs two h later. Cream application continued for an additional four days,
followed by sacrificing 24 h after the last treatment (Scheme 6.1, step 2, post-treatment).
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Scheme 6.1. Schematic illustration of (step 1): extraction, nanosizing and labeling of
ginseng polysaccharides (step 2): photo-protective effect of ginseng polysaccharides on
SKH1 hairless mice through two different routes (i) pre-treatment with ginseng
polysaccharides and (ii) post-treatment with ginseng PS. Three different treatment groups
were used (a) bulk ginseng polysaccharides, (b) ginseng polysaccharides NPs and (c)
labeled ginseng polysaccharides NPs.

6.2.9 Sacrifice
Mice were anesthetized with an intraperitoneal injection of (100 mg/kg) ketamine and (6
mg/kg) xylazine solution. After being anaesthetized, a cardiac puncture was performed to
collect blood. Blood was centrifuged (Beckman Model TJ-6, U.S.A) at 3000xg for 30 min
and supernatant was collected and stored at -20˚C. Skin samples from the dorsal side of the
mice were also collected and were stored at -20˚C.
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6.2.10 Histological analysis
Biopsies that were obtained from the dorsal skin were fixed in 10% paraformaldehyde for
24 h. Samples were then embedded in paraffin and sectioned into 4 μm slices. The skin
samples were sent to the University Hospital (London, ON, Canada) Pathology department
for hematoxylin and eosin (H&E) staining. The stained slides were examined with a light
microscope.

6.2.11 Cytokines analysis
The remaining dorsal skin tissue was then washed in phosphate buffer saline solution (PBS,
pH 7.0) and sectioned into 60 mg pieces. These pieces were then homogenized and
centrifuged at 3000xg for 20 min. Total pro inflammatory cytokine (IL-6, IL-1β, TNF-α)
content in blood serum and skin samples was determined using their respective ELISA kit
per manufacturer’s instructions (BD biosciences). Briefly, a monoclonal capture antibody
specific for mouse cytokine (IL-6, IL-11β, or TNF-α) was coated onto the wells of a high
affinity binding 96 well plate overnight at RT. Plates were then washed using 300 µL/well
washing buffer (PBS + 0.05% TWEEN 20). After washing, plates were blocked for one
hour at RT with 200 µL/well of Assay diluent (PBS+ 10% fetal bovine serum). Following
incubation, plates were washed again as previously described after which100 µL/well of
samples (blood plasma or skin supernatant) were pipetted into plates in triplicate, followed
by standards and incubated at RT for two h. Plates were washed again, followed by
incubation for one hour at RT of 100 µL/well of working detector (biotinylated detector
antibody + streptavidin-horseradish peroxidase). After incubation and washing, 100
µL/well of substrate solution (TMB) was added which was acted upon by the bound
enzyme to produce colour. Cytokine quantification was performed using a
spectrophotometer Elisa plate reader (BiotekuQuant) at 450 and 570 nm.
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6.2.12. DNA immunofluorescence measurements
Cells were fixed in 4% paraformaldehyde for 10 min, permeabilized for 10 min in 0.2%
Triton X-100, and blocked in 10% normal goat serum for 1 h at room temperature. The
slides were incubated with anti-γ-H2AX antibody for 1 h, washed in phosphate-buffered
saline, and incubated with Alexa Fluor 488-conjugated goat anti-rabbit secondary for 1 h
at room temperature. Cells were washed in phosphate-buffered saline and mounted using
Vectashield mounting medium with 4,6 diamidino-2-phenylindole . Fluorescence images
were captured using confocal microscopy.

6.3 Results and discussions
6.3.1 Morphology and fluorescent labeling of ginseng PS NPs
Our previous methodology was utilized for the extraction of ginseng PS from NA ginseng
root, nanosizing of ginseng PS using a microfluidic device with subsequent fluorescent
labeling of ginseng PS for the present study. This corresponds to step 1 in Scheme 6.1.
TEM was used to confirm the particle size and shape of ginseng PS NPs prepared by
microfluidic device and size distribution was estimated from these TEM images by using
‘ImageJ’ software. From the TEM images (Figure 6.1a), it is clearly observed that the NPs
were formed with uniform spheres and smooth surfaces. From the particle size distribution
chart (Figure 6.1b), it is seen that the NPs are in the range of 15-30 nm, with an average
size of 20 nm. This small sized and narrow size distributed NPs are most desirable for the
controlled drug delivery system [33]. Nanosized ginseng PS were then labeled using
fluorescein-5-thiosemicarbazide as dye for tracking the transport of therapeutic agent PS
NPs inside the cell. Confocal laser scanning microscopy (CLSM) was used to characterize
the FTSC dye labeled ginseng PS NPs. Figure 6.1c represents the dark field image of
labeled ginseng PS NPs, where the green signal emits from the fluorescent dye within
ginseng PS NPs.
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Figure 6.1. (a) TEM image of ginseng polysaccharides nanoparticles prepared by
microfluidic system; (b) size distribution of ginseng polysaccharides nanoparticles
measured by ‘Image J’ software; and (c) Confocal laser microscopic image of dye labeled
ginseng polysaccharides nanoparticles.

6.3.2 Visible changes of the mice skin

The visible appearance of the mice skin was observed to investigate the changes in skin
with UVB exposure. Figure 6.2a represents the visual assessment of control mouse skin
without UVB exposure that means the normal mouse skin structure. Control mouse
exposed to UVB showed the dermal changes (Figure 6.2b). There was wrinkle, red area
and blister formation on the dorsal skin of the control mouse with UV exposure. Visual
observation of the ginseng PS pre-treated mouse skin showed better skin structure (Figure
6.2c), there was no wrinkle formation as of without treatment control group.

152

Figure 6.2. Visual assessment of mouse skin (a) control mouse skin (without UVB
exposure), (b) control mouse skin (after UVB exposure), and (c) mouse skin pre-treated
with ginseng polysaccharides nanoparticles (after UVB exposure).

6.3.3 Histological observations: pre-treatment
The Hematoxylin and Eosin stained skin samples were investigated using optical
microscopy for histology analysis. Figure 6.3a represents the control skin structure without
UVB exposure. Here, we observed that they have regular skin structure, epidermis and
dermis boundary layer are clearly marked and there is normal cellular organization within
the dermis of the skin. For the other ginseng PS treated skin samples without UVB
exposure (Figure 6.3 b-d), the skin did not show any significant structural changes
compared to the control (Figure 6.3a) indicating that the treatment cream itself is not
detrimental for the mouse. After UVB exposure in the control mice, the skin structure was
changed. There was an apparent disruption in the cells of the basal layer such that the
boundary between the epidermis and the dermis disappeared and was marked by a
thickening of the epidermis layer. In addition, UVB irradiation also resulted in an increase
in intra-epidermal and dermal blisters within the skin (Figure 6.3e). On the other hand,
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after UVB exposure, ginseng PS (bulk), ginseng PS NPs and labeled ginseng PS NPs were
able to provide protection against UVB damage. In case of bulk PS treatment, there was a
small area with intra-epidermal lesion or blister and disruption of basal layer observed
(Figure 6.3f). Alternatively, PS NPs and labeled PS NPs showed excellent protection
against UVB radiation as the materials maintained the epidermal and dermal boundary and
decreased blister formation (Figure 6.3g, h), in comparison to the control mouse skin with
UVB exposure (Figure 6.3e).

6.3.4 Histological observations: post-treatment

In the case of post-treatment with ginseng PS after UVB irradiation, there was no apparent
difference between the control and other treated mice skin structure (Figure 6.3 i-l). All the
structures are visually similar and there is no definite epidermis and dermis boundary layer
observed.

This is associated with increased epidermal proliferation and increased

expression of markers of inflammation, DNA damage and apoptosis [34]. Therefore, all
these results indicate that pre-treatment of ginseng PS is beneficial in preventing epidermal
proliferation and maintain skin integrity which is not observed in post-treatment study.
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Figure 6.3. Histological observation on SKH-1 hairless mice skin after H and E staining.
Treatment cream was applied for 4 days and then sacrificed for observation; (a) control
mouse skin (no treatment), (b) treated with bulk polysaccharides, (c) treated with
polysaccharides nanoparticles, (d) treated with labeled polysaccharides nanoparticles.
After three consecutive days of treatment mice were sacrificed 24 h after UVB irradiation
(pre-treatment); (e) control mouse skin (no treatment, UVB applied), (f) pre-treated with
bulk polysaccharides, (g) pre-treated with polysaccharides nanoparticles, (h) pre-treated
with labeled polysaccharides nanoparticles. After UVB applied, mice were treated with
cream for four consecutive days (post-treatment); (i) control mouse skin (no treatment), (j)
post-treated

with

bulk

polysaccharides,

(k)

post-treated

with

polysaccharides

nanoparticles, (l) post-treated with labeled polysaccharides nanoparticles. Epidermal
blisters are marked as arrows.
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6.3.5 Cytokines analysis
UVB light exposure of the skin induces many changes to the skin microenvironment,
including the production of cytokines which causes the inflammation on the skin [35].
Therefore, the production of cytokines tumor necrosis factor alpha (TNF-α), Interleukin
(IL) -1β and IL-6 were analyzed for pre-treated mice skin and blood serum sample.
Analysis of cytokine levels, within skin, demonstrated that there was a significant increase
in IL-6, IL-1β, and TNFα levels in the control (base cream) group in comparison to the
non-irradiated control (Figure 6.4 a-c). Additionally, analysis of the blood serum revealed
that there was a significant increase in TNFα and IL-1β levels after UVB exposure for the
control group (Figure 6.4 d,e). This indicates that UVB exposure enhances the production
of proinflammatory cytokines within the skin and blood that matches with reported
literature [35, 36]. Further, cytokine production of the ginseng PS materials treated skin
and blood serum was investigated. It was found that pre-treatment with ginseng PS
materials significantly decreased all measured cytokine levels upon UVB exposure
compared to the control with UVB (Figure 6.4 a-e). PS NPs and labeled PS NPs treated
mice skin showed the significantly decreased the production of cytokines in the skin
sample. Though the bulk PS produced a higher amount of TNF-α and IL-1β compared to
the PS NPs and labeled PS NPs treated skin sample, but they were able to decrease the
mentioned cytokines compared to the control group. Bulk PS produced almost the same
amount of IL-6 as compared to the PS NPs and labeled PS NPs. This amount is significantly
lower compared to the control group with UVB irradiation. All these results indicate that
all three treatment groups PS NPs, labeled PS NPs and bulk PS are able to protect against
UVB induced increase in skin cytokine levels for IL-6. In addition, PS NPs and labeled PS
NPs are also able to resist TNF-α, IL-1β over production in the skin and blood serum.

Next, this study was carried out to examine whether ginseng PS applied after the injury
had any effect on the recovery process of the skin. Cytokine analysis revealed that after
UVB exposure, there was no significant difference in TNFα or IL-1β production levels
with all three ginseng PS treatment groups compare to the control with UV (Figure 6.4 f,g).
Alternatively, there was a little decrease in TNFα and IL-1β production of PS treated mice
within blood serum in comparison to the control group (Figure 6.4 h,i).
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Figure 6.4. The effect of UVB irradiation (300 mJ/cm2) and ginseng polysaccharides on
the production of cytokines within blood serum and skin of SKH-1 mice. For pre-treatment
experiment, mice were given ginseng polysaccharides treatments or control (base cream)
for three days followed by UV irritation and sacrificed. For post-treatment study, UVB
radiation was first applied followed by applying either ginseng polysaccharides treatments
or control (base cream) for three days and sacrificed. (a) TNF-α (pre-treatment - skin), (b)
IL-1β (pre-treatment - skin), (c) IL-6 (pre-treatment - skin), (d) TNF-α (pre-treatment –
blood), (e) IL-1β (pre-treatment – blood), (f) TNF-α (post-treatment - skin), (g) IL-1β (posttreatment - skin), (h) TNF-α (post-treatment – blood), (i) IL-1β production (post-treatment
– blood). Blood serum was used for cytokines analysis. Skin was homogenized and
supernatant was used for analysis of respective cytokine by ELISA.
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6.3.6 DNA immunofluorescence

The heterocyclic bases of DNA are a major UVB absorbing chromophore in the skin [35].
The absorption leads to damage of the DNA, which may result in DNA lesions. The DNA
double-strand break (DSB) is a serious lesion that can initiate genomic instability,
ultimately leading to skin cancer [37]. These lesions have been shown in epidermal basal
and super basal layers [35]. γH2AX is a sensitive target for looking at DSBs in skin cells.
Therefore, γH2AX was used as a biomarker to monitor DNA damage produced by UVB
irradiation in the investigated mice skin, which was further analyzed using confocal
microscope. We investigated the DSBs formation by examining γ-H2AX foci formation.
Figure 6.5a-c represents fluorescence images of control mouse skin without irradiation,
control mouse after UVB exposure and ginseng PS NPs treated mouse skin respectively.

As H2AX phosphorylation in response to DNA damage results in the formation of discrete
γ-H2AX foci at the sites of DNA double-strand breaks, so in order to allow direct
comparisons all the images were obtained using the same parameters e.g. brightness,
contrast, magnification. In case of control sample without UV, poor γ-H2AX focus
obtained due to the absence of DSB in cells (Figure 6.5a). In contrast, control skin with
UV showed increased γ-H2AX staining in the skin which indicates higher number of DSBs
in the skin cell (Figure 5.5b). However, PS NPs treated mouse skin sample (Figure 6.5c)
showed lower γ-H2AX staining compare to the control with UVB. Therefore, ginseng PS
NPs treatment decreases epidermal DNA damage, preserving skin integrity.
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Figure 6.5. Assessing the effects of UVB irradiation on DNA damage using γ-H2AX
immunofluorescence staining on investigated mice skin; (a) control mouse skin without
UVB irradiation, (b) control mouse skin after UVB exposure, (c) ginseng polysaccharides
nanoparticles treated mouse skin sample. The marked arrow represents strong
immunofluorescence response. Control UV treated mice showed increase staining in
comparison to UV polysaccharides nanoparticles treated mice.

6.3.7 Confocal imaging of the skin
As one of the investigated treatments is labeled ginseng PS NPs, we further analyzed the
structure of skin by inverted confocal microscopy for detailed analysis. Figure 6.6
represents the same skin structure with three different contrast modes bright field image
(Figure 6.6a), dark field image (Figure 6.6c) and merge image (Figure 6.6b) of UVirradiated labeled ginseng PS NPs treated mouse skin sample. In the case of bright field
image, we observed the structure of skin which indicates they have regular skin structure,
epidermis and dermis boundary layer are clearly observed and no disruption in the basal
layer, apoptotic cells and intra-epidermal blister observed as of without UV exposure
control mice skin (Figure 6.3a). But from this image, it is not possible to obtain the detail
information about the distribution of therapeutic agent ginseng PS within the skin cell. The
dark field image (Figure 6.6c) showed the green fluorescent signal which indicates the
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presence of fluorescent dye within the skin. When we observed the merge image (Figure
6.6b), this gives us detailed information about the location of labeled ginseng PS NPs.
There is a concentrated layer formed at the outermost layer of epidermis and also at stratum
corneum (SC) (Figure 6.6b). The PS passes through the epidermis boundary layer to the
dermis portion through the hair follicle (HF) and sweat gland (SG) (Figure 6.6d) where the
intense fluorescence signal is observed. Labeled ginseng PS NPs were also localized in the
dermal blood vessels (BV) (Figure 6.6e). Again, Figure 6.6f represents a 3D image of the
skin structure, which also showed that labeled PS forms a concentrated layer on the
keratinocytes and then passes through the epidermis layer to dermis portion and distributed
throughout the different cellular organization. Therefore, all the fluorescent images
suggest the potential application of fluorescent labeled ginseng PS NPs for treating and
monitoring of the UVB induced photoaged skin.

Figure 6.6. Confocal micrograph of SKH1 female mice skin sample with in vivo topical
administration of FTSC labeled ginseng polysaccharides nanoparticles; (a) bright field
image, (b) merge image, stratum corneum (SC) (c) dark field image, (e) merge image with
160

indication of hair follicle (HF) and sweat gland (SG), (f) dark field image with indication
of blood vessel (BV) in dermis, (g) 3D image of skin structure.

The UV radiation is the most described physical attack. It causes skin damage resulting in
both pre-cancerous and cancerous skin lesions, and acceleration of skin aging [38]. In this
study, we found that ginseng PS can effectively reduce skin damage and promote antiwrinkling processes in UV-irradiated hairless mouse model. Ginseng PS acts as an antioxidant in vitro by scavenging reactive oxygen and nitrogen species and chelating redoxactive transitions metal ions [21, 39]. In an observation of skin wrinkle, ginseng PS NPs
reduced wrinkle formation compared to the control mice group without any treatment.
According to the histological observation with E and S stains, the epidermis and dermis
boundary layer were diminished, inter-epidermal blister were observed in the control
mouse group with UV, while they were almost intact with a regular arrangement in pretreatment groups. However, epidermis and dermis boundary layer was almost disappeared
in the post-treatment groups. Thus, these data support that the damage on the skin tissue
reduced by pre-treatment with ginseng PS.

Acute UV skin exposure induces an immediate inflammatory response with erythema and
leukocyte infiltration. In fact, it has been suggested that UV-induced inflammation is
mediated by DNA damage leading to the release of pro-inflammatory cytokines [8, 40]. In
agreement with the inflammatory character of the UVB irradiation, we investigated the
production of pro-inflammatory cytokines within skin and blood serum of the investigated
mice. The results revealed that UVB irradiation induces the increased production of proinflammatory cytokines within skin and blood serum of control mice. In contrast, with pretreatment with ginseng PS reduced the production of all cytokines after UVB irradiation.
However, in case of post-treatment group, they did not show any significant change of
cytokines level compared to the control UV group.

Altogether, the findings of this study indicated that PS derived from NA ginseng were
effective in the wrinkle improvement by reducing epidermal damage, alleviating
inflammation and skin barrier damage in an in vivo hairless mouse model. In particularly,
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pre-treatment with ginseng PS had a better protection against visible changes (wrinkling),
histological alterations and cytokines production was observed compare to the posttreatment with the ginseng PS. Therefore, NA ginseng PS appears to be a promising photoprotector capable of attenuating the deleterious effects of UV on human skin.

6.4 Conclusions
To our knowledge, this is the first study to investigate the photo protective effect of NA
ginseng PS using SKH1 hairless mice as animal model. The study shows that UVB
irradiation induces the increased production of pro-inflammatory cytokines within both
blood serum and the skin. Additionally, increased γ-H2AX staining in the skin
demonstrated higher UVB irradiation levels. Pre-treatment with the ginseng PS proved to
be effective at inhibiting the UVB-induced rise in all measured pro-inflammatory cytokine
levels. Additionally, the pre-treatment of ginseng PS inhibited epidermal proliferation and
blister formation. A proposed mechanism for this protective effect would be that ginseng
PS inhibit the initiation of the pro-inflammatory cascade, thus reducing inflammatory skin
damage. Therefore, our data suggest that topical application of pre-treatment of ginseng
PS material significantly protect skin structure against UVB induced photo aged mouse
skin.
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7.1

Conclusions

Ginseng roots are well known to consist of a number of active constituents including
polysaccharides, ginsenosides, peptides, polyacetylenic alcohols, and fatty acids [1].
Polysaccharides have been far less studied than ginsenosides, although they are believed
to provide various biological activities including anti-carcinogenic, anti-aging,
immunostimulatory and antioxidant activity [2-4]. In particular, COLD-FX®, isolated
from NA ginseng root, contains 80% poly-furanosyl-pyranosyl-saccharides, and has been
clinically used for the prevention of upper respiratory tract infections [5], although the
mechanism is poorly understand. It has been found that due to their large aggregate size, a
significant portion of these polysaccharide macromolecule chains cannot pass the cell
barrier of the gastrointestinal tract. Nanosizing of the ginseng polysaccharide chains has
not been previously examined.
In this work, we synthesized ginseng PS NPs using two conventional wet chemical
methods including nanoprecipitation and the reverse microemulsion technique. The
nanoprecipitation technique is a simple processing method for the fabrication of ginseng
PS NPs. However, it is difficult to add anti-solvent (acetone) in a controlled manner using
this technique, leading to the formation of a wide size distribution. Here the particle size
distribution was observed from 5-100 nm with an average size of 65 nm. In the next
procedure, this problem was significantly minimized by using the reverse microemulsion
technique for the preparation of ginseng PS particles. As the surfactant helps to keep the
NPs separated from each other, a better size distribution was observed compared to that
prepared by the nanoprecipitation method. Here, the nanoparticles were obtained in the
size range from 10 to 80 nm with an average size of 50 nm. Using this method, the major
challenge is the complex washing steps to remove both the surfactant and oil phases[13].
Further, we synthesized ginseng PS NPs in a microfluidic channel using aqueous solution
of PS and acetone as anti-solvent in a controlled nanoprecipitation process. The rapid and
continuous microfluidic process was carried out at ambient temperature and atmospheric
pressure, based on the nanoprecipitation concept of particle formation examined in the
batch process. In this study, three different ratios of solvent and antisolvent (1:10, 1:15,
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and 1:20) were used to tune the size of NPs. The results reveal that increasing the ratio of
solvent-antisolvent improved the monodispersity of the ginseng PS NPs. The most narrow
size distribution was observed for the ratio 1:20. Further increasing the amount of antisolvent gave no significant change. The prepared PS NPs were unimodal and spherical in
shape from 15-30 nm, with an average size of 20 nm. In addition, the immunostimulating
effect of the PS NPs was investigated on Murine macrophage cell lines, with the results
revealing an enhanced production of all proinflammatory mediators in a concentration
dependent manner. Also, the NPs prepared using the microfluidic system were the best
immunotimulating agent amongst the techniques investigated, attributed to their smaller
and more uniform size.

Although the biological activity of ginseng PS has been reported by several groups, no
research has explored their cellular uptake and biodistribution, owing to the lack of suitable
detection techniques in living cells. Hence, we have developed a novel, simple and efficient
procedure for the fluorescent labeling of ginseng PS, in order to examine their cellular
distribution using confocal laser scanning microscopy (CLSM). This procedure utilized a
one-pot

strategy with

fluorescein-5-thiosemicarbazide

(FTSC)

to

introduce

a

thiosemicarbazide group onto the aldehyde group at the reducing saccharide end to form a
stable amino derivative through reductive amination. The prepared labeled PS have a
diameter of 20 nm with an excellent fluorescent intensity. We demonstrated cellular uptake
as a function of time and observed that after 4h of treatment, the labeled PS was
successfully uptaken by cell lines and the materials were stable even after 48 h of treatment.
In addition, PS-FTSC derivative exhibited almost no cytotoxicity against tumor induced
murine macrophage cell lines. The labeled PS NPs were found to cause a significant
increase in macrophage production of cytokines TNF-α, IL-1β, Il-6 and in the production
of antimicrobial product NO. Therefore, the developed approach provides a convenient and
highly efficient fluorescent labeling procedure for understanding the mechanism of ginseng
PS uptake that can be considered as a potential therapeutic agent against tumor or cancer
cell proliferation.
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Until now, there is no report on encapsulation of ginseng PS within gelatin carrier. Herein,
an in situ route was developed to encapsulate ginseng PS within gelatin nanocarrier through
a water soluble cross-linking agent. The average diameter of gelatin nanosphere is
approximately 180 nm±10 nm which showed excellent swellability. The encapsulated PS
was homogeneously distributed inside the gelatin NPs, as observed using confocal
microscopy. The release profile was monitored for 6 days and found to follow a diffusioncontrolled release mechanism. The degree of cross-linking and pH sensitivity of the
nanosystems were investigated, revealing that increasing the cross-linker amount
decreased both the release rate of PS from gelatin NPs and the swelling ratio of the
hydrogel. The experimental results also indicate that the developed nanosystems are pH
sensitive with acidic conditions are delaying the release profile of PS from gelatin NPs. All
the studies confirm that the gelatin NPs were able to encapsulate ginseng PS, providing a
carrier for prolonged delivery of ginseng PS.
Ultraviolet (UV) radiation induced skin damages may result in cancerous skin lesions, and
acceleration of skin aging. This process involves an imbalance of the endogenous
antioxidant system that leads to an increase of free radical levels and inflammation.
Therefore, antioxidant supplementation might inhibit such imbalance. In this regard,
ginseng root is a promising drug, as they have proven anti-oxidative and anti-inflammatory
property. To our knowledge, this is the first study to investigate the photo protective effect
of NA ginseng PS using SKH1 hairless mice as the animal model. The study showed that
UVB irradiation induces the increased production of pro-inflammatory cytokines within
both blood serum and the skin. Additionally, increased y-H2AX staining in the skin
demonstrated higher UVB irradiation levels. Pre-treatment with the ginseng PS proved to
be effective at inhibiting the UVB-induced rise in all measured pro-inflammatory cytokine
levels. Additionally, the pre-treatment of ginseng PS inhibited epidermal proliferation and
blister formation. A proposed mechanism for this protective effect would be that ginseng
PS inhibit the initiation of the pro-inflammatory cascade, thus reducing inflammatory skin
damage. Therefore, our data suggest that topical application of pre-treatment of ginseng
PS material significantly protect skin structure against UVB induced photo aged mouse
skin.
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7.2

Recommendations

The following recommendations will be useful in the future investigations of this study:



Detailed study on microfluidic droplet formation and the effects of microchip
geometry on polysaccharide nanosphere size can be simulated using computational
fluid dynamics (CFD).



Study the theoretical releasing kinetics based on real phenomenon such as
diffusion, degradation, and erosion to understand the release profile of ginseng PS
from gelatin nanocarriers.



Further functionalized of the gelatin nanoparticles can be carried out which would
be more efficient for targeted drug delivery. Chemical modification of gelatin is
important to enhance the desired physicochemical properties such as solubility,
hydrophilicity, stability, biocompatibility. Long circulation times for drugs in the
body is the key to successful drug delivery and drug targeting to the site of action.
Certainly, more controlled surface modification studies would be useful in
achieving these goals.



This study was based on the improving the efficiency of ginseng PS and their
immunostimulating property. We observed nanosizing of ginseng PS enhance the
immune-stimulation which is a useful effect for tumor or cancer therapy. It is
possible to investigate further using commercial cancer drug along with the ginseng
PS NPs which might be considered as a potential therapeutic agent for cancer
treatment.



Labeling of ginseng PS using quantum dots (QDs) instead of fluorescent dye for
biological imaging. The advantages of QDs over fluorescent dye includes broad
absorption followed by narrow emission in visible range and they are relatively
more robust than fluorescent dyes against photobleaching which suits them for long
term imaging



In this study, we have preliminary investigation of oral gavage using Albino male
mice. Further investigations are necessary to collect the organs and/or tissues
(spleen, kidney and peritoneal tissue) for histology analysis. In addition, bio172

distribution study of the collected tissue can also be carried out using confocal
microscopy.


In this study, we used standard deviation equation
∑

and Maximum S= ̅ +

=

∑(

̅)

where, mean, ̅ =

and minimum S= ̅ − and Co-efficient of variation = ̅ .

If co-efficient of variation>=1 then relatively high variation and if <1 then
considered low, that means data value are less spread. In our experiment, we found
co-efficient of variation less than 1, which indicates data value are less spread. For
more statistically viable, this statistical analysis can be carried out using ‘GraphPad
Prism software’ which will give more significant information about the analysis of
variance.
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